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ABSTRACT: Enantioselective catalytic methods allowing the 
addition of both a nucleophile and an electrophile onto diazo 
compounds give a fast access into important building blocks. 
Herein, we report the highly enantioselective oxyalkynyla-
tion of diazo compounds using ethynylbenziodoxol-(on)e 
(EBX) reagents and a simple copper bisoxazoline (BOX) cata-
lyst. The obtained -benzoyloxy propargylic esters are useful 
building blocks, which are difficult to synthesize in enanti-
opure form using other methods. The obtained products 
could be efficiently transformed into vicinal diols and α-
hydroxy propargylic esters without loss in enantiopurity. 
Due to the different biological and optical properties of 
enantiomers, the synthesis of enantiopure compounds is an 
important field of research in organic chemistry. In this re-
spect, enantioselective metal-catalyzed reactions of diazo 
compounds proceeding via carbenoid intermediates have 
been highly successful.1 Asymmetric cyclopropanation and 
insertion into carbon or heteroatom- hydrogen bonds are 
now broadly used for the asymmetric synthesis of important 
building blocks. The generation of ylides by reaction of elec-
trophilic carbenes with nucleophiles opened the way for [2,3] 
sigmatropic rearrangements and cycloaddition reactions.2 
Recently, researchers have focused on direct reactions of 
ylides generated from diazo compounds with electrophiles, 
allowing the introduction of more diverse functionalities on 
the carbon center.3 The development of enantioselective 
variations of such processes is highly challenging. Recent 
breakthroughs have been realized based on elegant coopera-
tive catalytic systems involving late metal catalysts such as 
rhodium/iridium,4 palladium5 and ruthenium,6 and either a 
chiral phosphoric or Lewis acid (Scheme 1A). Nevertheless, 
this approach is limited to electrophilic partners that can be 
activated by Brønsted or Lewis acids, and it is based on a 
relative complex dual catalyst system. Transformations rely-
ing on a single chiral catalyst remain extremely rare in this 
new type of carbene transformations, including two exam-
ples of rhodium catalysts7 and an organocatalytic system 
specific to diazo compounds derived from oxindoles.8 
Surprisingly, despite their success in enantioselective cy-
clopropanation and X-H insertion reactions,9 copper cata-
lysts have been used so far only in racemic multi-component 
reactions involving diazo compounds.10 Recently, our group 
developed a copper-catalyzed oxyalkynylation of diazo com-
pounds11 based on the use of EthynylBenziodoXolones (EBX) 
reagents.12 Herein, we report the successful development of 
an enantioselective variation of this transformation, which 
constitutes the first asymmetric simultaneous introduction 
of an alkyne and an ester onto a diazo compound (Scheme 
1B). Importantly, the reaction required a single copper cata-
lyst bearing a broadly available BOX ligand, and gave prod-
ucts in high yield with up to 98% ee. The obtained propar-
gylic benzoyloxy esters are useful building blocks, which are 
difficult to access using traditional methods, such as alkyne 
addition to aldehydes,13 due to the sensitivity of the products 
and required starting materials to basic conditions.14 Fur-
thermore, they could be easily transformed into other im-
portant building blocks, such as propargylic alcohols. 
Scheme 1. Enantioselective transformations of diazo 
compounds. 
 
We started our investigations by screening various ligands,15 
using ethyl diazoacetate (1a) with 1-[(triiso-
propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)- one (TIPS-EBX, 
2a) and Cu(OTf)2 as the copper source (Table 1).16 Several 
classes of ligands, such as diimines, Salen, Phox or biphos-
 phines gave either low selectivity or low conversion.15 tBu-
BOX ligand 4a gave the desired propargylic ester 3a in excel-
lent yield with a promising 56% ee (entry 1). The use of  cy-
clopropyl and cyclopentyl derived BOX ligands (4b and 4c) 
didn’t improve the enantioselectivity (entries 2 and 3). In-
dane-BOX ligand 4d gave results identical to the ones ob-
tained with ligand 4a, whereas a slightly better enantioselec-
tivity was observed with cyclopropyl substituted ligand 4e 
(entries 4 and 5). Among the solvents tested15 (entries 6-8), 
chlorobenzene emerged as the best solvent (84% yield with 
70% ee, entry 7). Generating a cationic complex in situ from 
AgSbF6 and CuCl provided a slight improvement (entry 9). 
No reaction was observed when using AgClO4 or NaB-
ARF(entries 10 and 11). AgNTf2 gave the desired product in 
91% yield and 84% ee (entry 12). Without AgNTf2, no product 
was obtained (entry 13). Finally, the enantioselectivity could 
be improved to 90% by lowering the concentration of the 
reaction (entry 14).  






Time (h) Yieldb (%) eec (%) 
1 Cu(OTf)2 4a DCE 0.5 97 56e 
2 Cu(OTf)2 4b DCE 0.5 98 55e 
3 Cu(OTf)2 4c DCE 0.5 98 54e 
4 Cu(OTf)2 4d DCE 2 98 54 
5 Cu(OTf)2 4e DCE 0.5 97 62 
6 Cu(OTf)2 4e DCM 0.5 98 40 
7 Cu(OTf)2 4e PhCl 2 84 70 
8 Cu(OTf)2 4e xylene 2 79 69 
9 CuCl/AgSbF6 4e PhCl 1 89 72 
10 CuCl/AgClO4 4e PhCl 24 <5 ndf 
11 CuCl/NaBARF 4e PhCl 24 <5 nd 
12 CuCl/AgNTf2 4e PhCl 18 91 84 
13 CuCl 4e PhCl 24 <5 nd 
14d CuCl/AgNTf2 4e PhCl 18 95 90 
aReaction conditions: 0.30 mmol ethyldiazoacetate (1a), 
0.15 mmol TIPS-EBX (2a), copper catalyst (2.0 mol%), ligand 
(2.5 mol%), solvent (0.05 M), for entries 9-12 and 14: AgX or 
NaBARF (2.0 mol%). bYield after purification by column 
chromatography. cObtained by chiral HPLC. d0.025 M in-
stead of 0.05 M. e The opposite enantiomer of the product 
was obtained. fnd = not determined. 
 
To further improve the enantioselectivity, we investigated 
the influence of the structure of the α-diazo ester (Scheme 
2A). Aliphatic diazoesters of different steric bulk afforded 
products 3a-h in 85-92% ee. Hindered aryl diazo esters18 pro-
vided higher enantioselectivities (up to 97%) (products 3i-k). 
The reaction was not limited to α-diazo esters. Both ethyl 
diazomethanesulfonate and diethyl (diazome-
thyl)phosphonate gave the desired product 3l and 3m in high 
yield and moderate to high selectivity (Scheme 2B). Finally, 
diazo Weinreb amide also delivered the product 3n, which 
open up possibilities for further derivatization.19 
Scheme 2. Scope of diazo compounds with TIPS-EBX 
(2a). 
 
We next examined the scope of R-EBX reagents using 2,6-
di-tert-butyl-4-methylphenyl 2- diazoacetate (1k) (Scheme 
3). Electron-donating and -withdrawing groups were well 
tolerated on the aryl ring of TIPS-EBX (2a) (products 3o-t). 
The reaction was successful with a triethyl silyl group (prod-
uct 3u), whereas no product could be isolated with a trime-
thylsilyl group. Aliphatic EBX reagents bearing substituents 
such as long alkyl chain, chloro, TMS-alkyne and a cyclopro-
pyl group worked efficiently in this transformation, giving 
products 3v-y. Finally, EBX reagents bearing aryl substituents 
on the alkyne led to the desired products 3z-c’ in excellent 
yields and good enantioselectivities. 
The absolute configuration of 3o could be determined by 
X-ray analysis (Figure 1A).20 The observed stereochemistry 
would be in agreement with an attack of the carboxylate of 
the reagent in the free quadrant opposite to the ester group 
on a three coordinate copper carbene complex with a 90° 
angle between the ligand and the carbene plan,9g followed by 
stereospecific alkynylation with retention of configuration (I, 
Figure 1B). Further studies will be needed to support the 





 Scheme 3. Scope of R-EBX reagents. Ar = 2,6-di-tert-
butyl-4-methylphenyl. 
 
When (-) menthol diazoacetate 1o was subjected to the 
standard conditions, the desired product 5 was obtained in 
good yield with 95:5 d.r. (Scheme 4A).21 The use of the S-
enantiomer ent-4i of ligand 4i afforded the other diastere-
omer 6 in good yield with 6:94 d.r, demonstrating that the 
configuration at the new stereocenter could be controlled by 
the chiral catalyst. Similar results were obtained with (+) 
menthol diazoacetate 1p. All four diastereomers can there-
fore be obtained in good yield and selectivity. Good ligand 
control over the stereoselectivity could also be achieved with 
more complex diazo compounds 1q and 1r derived from ster-
oids (Scheme 4B).  
Figure 1. Absolute configuration and stereoinduction 
model. 
 
The obtained products were then further transformed into 
useful building blocks for organic synthesis (Scheme 5). 
Compound 3k was synthesized on gram scale in 98% yield 
with 95% ee. The benzoyl group could be readily removed 
using DIBAL-H, thus affording the α-hydroxy propargylic 
ester 11 in 99% yield with retention of enantiopurity. Fur-
thermore, vicinal diol 1222 could be synthesized by reduction 
of 3k using LiAlH4. Such alkynyl diol building blocks are use-
ful in synthetic chemistry, but are usually accessed via longer 
multi step procedures.23  
Scheme 4. Reactions with menthol and steroids es-
ters. 
 
Reaction conditions: 0.30 mmol diazoacetate (1), 0.15 
mmol TIPS-EBX (2a), CuCl (2.0 mol%), ligand (2.5 mol%), 
AgNTf2 ( 2 mol%), PhCl (0.025 M), 25 °C. R = 2-iodobenzoyl. 
Scheme 5. Scale up and product modifications. 
 
In summary, we have developed a highly enantioselective 
oxyalkynylation of diazo compounds. This transformation is 
the first example of copper-catalyzed addition of both a nu-
cleophile and an electrophile onto a carbenoid intermediate. 
A broad range of EBX reagents and diazo compounds were 
well tolerated. The reaction proceeds under mild conditions, 
giving highly functionalized products with excellent yields 
and selectivities. The obtained products were efficiently 
transformed into useful building blocks, such as α-hydroxy 
propargylic esters and vicinal diols, in a single step without 
loss of enantioselectivity. Further extending this methodolo-
gy to other diazo compounds and hypervalent iodine rea-
gents is currently under investigation in our laboratory. 
Experimental procedures and analytical data for all new 
compounds. This material is available free of charge via the 
Internet at http://pubs.acs.org.  
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). The solvents were degassed 
by Freeze-Pump-Thaw method when mentioned. All chemicals were purchased from Acros, 
Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless stated otherwise. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was 
performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized with 
UV light, permanganate stain, CAN stain or Anisaldehyde stain. Melting points were measured on 
a Büchi B-540 melting point apparatus using open glass capillaries, the data is uncorrected. 1H-
NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in chloroform-d, 
DMSO-d6 or CD3OD, all signals are reported in ppm with the internal chloroform signal at 7.26 
ppm, the internal DMSO signal at 2.50 ppm or the internal methanol signal at 3.30 ppm as standard. 
The data is being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m 
= multiplet or unresolved, br = broad signal, app = apparent, coupling constant(s) in Hz, 
integration, interpretation).13C-NMR spectra were recorded with 1H-decoupling on a Brucker 
DPX-400 100 MHz spectrometer in chloroform-d, DMSO-d6 or CD3OD, all signals are reported in 
ppm with the internal chloroform signal at 77.0 ppm, the internal DMSO signal at 39.5 ppm or the 
internal methanol signal at 49.0 ppm as standard. Infrared spectra were recorded on a JASCO FT-
IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 
(w = weak, m = medium, s = strong, br = broad). High resolution mass spectrometric 
measurements were performed by the mass spectrometry service of ISIC at the EPFL on a 
MICROMASS (ESI) Q-TOF Ultima API. HPLC measurements were done on a Agilent 1260 
Infinity autosampler using a CHIRALPAK IA, IB, IC or ID column from DAICEL Chemical. 
Optical rotations were measured on a polarimeter using a 10 cm cell with a Na 589 nm filter. The 




2. Synthesis of Diazo-compounds 
Ethyl 2-diazoacetate (1a), benzyl 2-diazoacetate (1b), and tert-butyl 2-diazoacetate (1c) were 
directly purchased from Sigma Aldrich. 
 
2,4-Dimethylpentan-3-yl 2-diazoacetate (1d) 
 
Following a slightly modified procedure,1 a mixture of 2,4-dimethylpentan-3-ol (13) (3.50 mL, 
25.0 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 1.00 equiv), 
and xylene (5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene was 
evaporated and the residue was purified by flash column chromatography using 1:50 
EtOAc:pentane as mobile phase to afford 2,4-dimethylpentan-3-yl 3-oxobutanoate (15) as a 
colorless oil (4.2 g, 21 mmol, 84%). TLC (EtOAc:pentane, 1:20 v/v): Rf = 0.36, KMnO4;1H NMR 
(400 MHz, CDCl3): δ 12.17 (s, 0.08H, OH of enol form), 4.97 (s, 0.08H, vinyl H of enol form), 
4.60 (t, J = 6.1 Hz, 1H, OCH), 3.46 (s, 1.84H, CH3COCH2 of keto form), 2.26 (s, 2.76H, 
CH3COCH2 of keto form), 1.92 (s, 0.24H, CH3 of enol form), 1.87 (dq, J = 13.3, 6.8 Hz, 2H, 2 X 
CH(CH3)2), 0.86 (d, J = 6.8 Hz, 6H, CH(CH3)2), 0.83 (d, J = 6.7 Hz, 6H, CH(CH3)2); 13C NMR 
(100 MHz, CDCl3): δ 200.7, 167.0, 84.0, 50.1, 30.3, 29.2, 19.4, 17.1. Enol form,  13C NMR (100 
MHz, CDCl3): δ 175.2, 172.7, 89.6, 81.9. Some carbons of enol form were not resolved at 100 
MHz. The characterization data of keto form corresponded to the reported values.1 
Following a slightly modified procedure,1 to a solution of 2,4-dimethylpentan-3-yl 3-oxobutanoate 
(15) (1.0 g, 5.0 mmol, 1.0 equiv) in acetonitrile (6 mL was added triethylamine (660 mg, 6.50 
mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide 
S4 
 
(1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture was 
allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. 
The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The 
organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:20 
Et2O:pentane as mobile phase to afford 2,4-dimethylpentan-3-yl 2-diazoacetate (1d) as a yellow 
oil (800 mg, 4.35 mmol, 87%). TLC (Et2O:pentane, 1:9 v/v): Rf = 0.55, KMnO4; 1H NMR (400 
MHz, CDCl3): δ 4.73 (br s, 1H, CHN2), 4.62 (t, J = 6.2 Hz, 1H, OCH), 1.88 (dq, J = 13.4, 6.7 Hz, 
2H, 2 X CH(CH3)2), 0.88 (d, J = 6.8 Hz, 6H, CH(CH3)2), 0.85 (d, J = 6.7 Hz, 6H, CH(CH3)2); 13C 
NMR (100 MHz, CDCl3): δ 167.0, 83.1, 45.8, 29.4, 19.5, 17.1. The characterization data 
corresponded to the reported values.1 
 
Dicyclohexylmethyl 2-diazoacetate (1e) 
 
Following a slightly modified procedure,1 a mixture of dicyclohexylmethanol (16) (2.45 g, 12.5 
mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (1.78 g, 12.5 mmol, 1.00 equiv), and 
xylene (2.5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene was 
evaporated and the residue was purified by flash column chromatography using 1:50 
EtOAc:pentane as mobile phase to afford dicyclohexylmethyl 3-oxobutanoate (17) as a white solid 
(3.00 g, 10.7 mmol, 86%). Mp: 64.5–66.8 °C; TLC (EtOAc:pentane, 1:20 v/v): Rf = 0.36, KMnO4; 
1H NMR (400 MHz, CDCl3): δ 12.20 (s, 0.09H, OH of enol form), 4.99 (s, 0.09H, vinyl H of enol 
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form), 4.67 (t, J = 5.8 Hz, 1H, OCH), 3.47 (s, 1.8H, CH3COCH2 of keto form), 2.29 (s, 2.7H, 
CH3COCH2 of keto form), 1.95 (s, 0.27H, CH3 of enol form), 1.81–1.42 (m, 12H, 2 X Cy–CH and 
5 X Cy–CH2), 1.34–0.83 (m, 10H, 5 X Cy–CH2); 13C NMR (100 MHz, CDCl3): δ 200.9, 167.0, 
82.8, 50.2, 38.2, 30.4, 29.8, 27.4, 26.3, 26.2, 26.0. Enol form,  13C NMR (100 MHz, CDCl3): δ 
175.2, 172.8, 89.8, 80.8, 38.3, 21.2, some carbons of enol form were not resolved at 100 MHz; IR 
ν 2976 (s), 2928 (s), 2862 (m), 2109 (w), 1725 (m), 1646 (w), 1447 (m), 1403 (m), 1313 (m), 1246 
(m), 1188 (m), 1152 (m), 1056 (s), 891 (w); HRMS (ESI) calcd. for C17H28NaO3+ [M+Na]+ 
303.1931; found 303.1928. 
 
Following a slightly modified procedure,1 to a solution of dicyclohexylmethyl 3-oxobutanoate (17) 
(1.4 g, 5.0 mmol, 1.0 equiv) in acetonitrile (6 mL) was added triethylamine (660 mg, 6.50 mmol, 
1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide (1.1 g, 5.5 
mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture was allowed to 
warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. The residue 
was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The organic layer was 
separated, dried over MgSO4, and evaporated. The crude product was re-dissolved in acetonitrile 
(15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After vigorous stirring for 4 h, 
water (15 mL) was added and the reaction mixture was extracted with diethyl ether (2 X 30 mL). 
The combined organic layers were dried over MgSO4, and concentrated under reduced pressure. 
The crude product was purified by column chromatography using 1:40 Et2O:pentane as mobile 
phase to afford dicyclohexylmethyl 2-diazoacetate (1e) as a yellow solid (1.10 g, 4.16 mmol, 83%). 
Mp (Dec.): 81.2–83.2 °C; TLC (Et2O:pentane, 1:25 v/v): Rf = 0.52, KMnO4; 1H NMR (400 MHz, 
CDCl3):δ 4.73 (bs, 1H, CHN2), 4.67 (t, J = 5.9 Hz, 1H, OCH), 1.84–1.45 (m, 12H, 2 X Cy–CH and 
5 X Cy–CH2), 1.31–0.88 (m, 10H, 5 X Cy–CH2); 13C NMR (100 MHz, CDCl3): δ 167.0, 82.0, 45.9, 
38.4, 29.8, 27.4, 26.3, 26.2, 26.0; IR ν 2929 (s), 2855 (m), 2110 (s), 1692 (s), 1451 (w), 1377 (m), 
1242 (m), 1191 (s), 1099 (w), 991 (w), 931 (w); HRMS (ESI) calcd. for C15H24N2O2 [M+] 
264.1832; found 264.1836. 
 




Following a slightly modified procedure,1 a mixture of 2-phenylpropan-2-ol (18) (3.4 g, 25 mmol, 
1.0 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 1.00 equiv), and xylene 
(5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene was evaporated 
and the residue was purified by flash column chromatography using 1:5 EtOAc:pentane as mobile 
phase to afford 2-phenylpropan-2-yl 3-oxobutanoate (19) as a colorless oil (2.60 g, 11.8 mmol, 
48%). TLC (EtOAc:pentane, 1:4 v/v): Rf = 0.4, KMnO4; 1H NMR (400 MHz, CDCl3): δ 11.98 (s, 
0.1H, OH of enol form), 7.41–7.31 (m, 4H, ArH), 7.30–7.22 (m, 1H, ArH), 5.06 (s, 0.1H, vinyl H 
of enol form), 3.43 (s, 1.8H, CH3COCH2 of keto form), 2.24 (s, 2.7H, CH3COCH2 of keto form), 
1.93 (s, 0.3H, CH3 of enol form), 1.80 (s, 5.4H, OC(CH3)2Ar of keto form), 1.79 (s, 0.6H, 
OC(CH3)2Ar of enol form); 13C NMR (100 MHz, CDCl3): δ 200.9, 165.5, 145.0, 128.2, 127.1, 
124.2, 82.9, 51.1, 30.1, 28.3; Enol form, 13C NMR (100 MHz, CDCl3) δ 175.2, 171.7, 145.7, 128.1, 
126.8, 123.9, 90.6, 81.5, 28.9, 21.1. The characterization data corresponded to the reported values.2 
 
Following a slightly modified procedure,1 to a solution of 2-phenylpropan-2-yl 3-oxobutanoate 
(19) (1.1 g, 5.0 mmol, 1.0 equiv) in acetonitrile (6 mL) was added triethylamine (660 mg, 6.50 
mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide 
(1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture was 
allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. 
The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The 
organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:10 
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Et2O:pentane as mobile phase to afford 2-phenylpropan-2-yl 2-diazoacetate (1f) as a yellow oil 
(820 mg, 4.02 mmol, 80%). TLC (Et2O:pentane, 1:10 v/v): Rf = 0.17, KMnO4; 1H NMR (400 MHz, 
CDCl3): δ 7.41–7.32 (m, 4H, ArH), 7.28-7.24 (m, 1H, ArH), 4.72 (br s, 1H, CHN2), 1.81 (s, 6H, 
OC(CH3)2Ar); 13C NMR (100 MHz, CDCl3): δ 165.5, 145.6, 128.2, 127.0, 124.1, 82.4, 46.9, 28.9. 
The 1H NMR data corresponded to the reported values.2 
 
Adamantan-1-yl 2-diazoacetate (1g) 
 
Following a slightly modified procedure,1 a mixture of adamantan-1-ol (20) (3.81 g, 25.0 mmol, 
1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 1.00 equiv), and xylene 
(5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene was evaporated 
and the residue was purified by flash column chromatography using 1:50 EtOAc:pentane as mobile 
phase to afford adamantan-1-yl 3-oxobutanoate (21) as a colorless oil (5.2 g, 22 mmol, 88%). TLC 
(EtOAc:pentane, 1:20 v/v): Rf = 0.35, KMnO4; 1H NMR (400 MHz, CDCl3): δ 12.20 (s, 0.07H, 
OH of enol form), 4.85 (s, 0.07H, vinyl H of enol form), 3.32 (s, 1.85H, CH3COCH2 of keto form), 
2.22 (s, 2.8H, CH3COCH2 of keto form), 2.17-2.04 (m, 9H, 3 X CH and 3 X CH2 of adamantly 
group), 1.87 (s, 0.2H, CH3 of enol form), 1.69-1.55 (m, 6H, 3 X CH2 of adamantly group); 13C 
NMR (100 MHz, CDCl3): δ 201.2, 166.0, 81.9, 51.6, 41.0, 35.9, 30.7, 29.9. Enol form,13C NMR 
(100 MHz, CDCl3): δ 174.6, 172.3, 91.1, 80.7, 41.4, 36.0, 21.1, One carbon of enol form was not 
resolved at 100 MHz. The characterization data corresponded to the reported values.3 
Following a slightly modified procedure, to a solution of adamantan-1-yl 3-oxobutanoate (21) (1.18 
g, 5.00 mmol, 1.00 equiv) in acetonitrile (6 mL) was added triethylamine (660 mg, 6.50 mmol, 
1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide (1.1 g, 5.5 
mmol, 1.1 equi) in acetonitrile (6 mL) was added slowly. The reaction mixture was allowed to 
warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. The residue 
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was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The organic layer was 
separated, dried over MgSO4, and evaporated. The crude product was re-dissolved in acetonitrile 
(15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After vigorous stirring for 4 h, 
water (15 mL) was added and the reaction mixture was extracted with diethyl ether (2 X 30 mL). 
The combined organic layers were dried over MgSO4, and concentrated under reduced pressure. 
The crude product was purified by column chromatography using 1:20 Et2O:pentane as mobile 
phase to afford adamantan-1-yl 2-diazoacetate (1g) as a yellow solid (960 mg, 4.36 mmol, 87%). 
TLC (Et2O:pentane, 1:10 v/v): Rf = 0.54, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.60 (s, 1H, 
CHN2), 2.22-2.06 (m, 9H, 3 X CH and 3 X CH2), 1.69-1.61 (m, 6H, 3 X CH2); 13C NMR (100 
MHz, CDCl3): δ 165.9, 81.5, 46.7, 41.6, 36.1, 30.8. The characterization data corresponded to the 
reported values.3  
 
2,3,4-Trimethylpentan-3-yl 2-diazoacetate (1h) 
 
Following a slightly modified procedure,1 a mixture of 2,3,4-trimethylpentan-3-ol (22) (1.63 g, 
12.5 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (1.78 g, 12.5 mmol, 1.00 equiv), 
and xylene (2.5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene 
was evaporated and the residue was purified by flash column chromatography using 1:50 
EtOAc:pentane as mobile phase to afford 2,3,4-trimethylpentan-3-yl 3-oxobutanoate (23) as a 
colorless oil (1.5 g, 7.0 mmol, 56%). TLC (EtOAc:pentane, 1:20 v/v): Rf = 0.36, KMnO4; 1H NMR 
(400 MHz, CDCl3): 12.28 (s, 0.05H, OH of enol form), 4.94 (s, 0.05H, vinyl H of enol form), δ 
3.40 (s, 1.9H, CH3COCH2 of keto form), 2.33–2.21 (m, 4.85H, CH3COCH2 of keto form and 2 X 
CH(CH3)2), 1.44 (s, 2.85H, OCCH3 of keto form), 1.42 (s, 0.15H, OCCH3 of enol form) 0.95 (m, 
12H, 2 X CH(CH3)2); 13C NMR (100 MHz, CDCl3): δ 201.2, 166.3, 92.8, 51.5, 34.3, 30.2, 18.0, 
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17.8; Enol form, 13C NMR (100 MHz, CDCl3): δ 174.5, 172.8, 91.2, 76.0, some carbons of enol 
form were not resolved at 100 MHz. The characterization data corresponded to the reported values.4  
 
Following a slightly modified procedure,1 to a solution of 2,3,4-trimethylpentan-3-yl 3-
oxobutanoate (23) (1.07 g, 5.00 mmol, 1.00 equiv) in acetonitrile (6 mL) was added triethylamine 
(660 mg, 6.50 mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of 
tosyl azide (1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction 
mixture was allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced 
pressure. The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. 
The organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:35 
Et2O:pentane as mobile phase to afford 2,3,4-trimethylpentan-3-yl 2-diazoacetate (1h) as a yellow 
oil (800 mg, 4.05 mmol, 81%). TLC (Et2O:pentane, 1:25 v/v): Rf = 0.5, KMnO4; 1H NMR (400 
MHz, CDCl3): δ 4.60 (br s, 1H, CHN2), 2.26 (hept, J = 6.9 Hz, 2H, 2 X CH(CH3)2), 1.41 (s, 3H, 
OCCH3), 0.93 (m, 12H, 2 X CH(CH3)2); 13C NMR (100 MHz, CDCl3): δ 166.1, 91.9, 46.5, 34.5, 
18.1, 18.0, 17.8. The 1H NMR data corresponded to the reported values.4  
 
2,6-Diisopropylphenyl 2-diazoacetate (1i) 
 
Following a slightly modified procedure,1 a mixture of 2,6-diisopropylphenol (24) (4.46 g, 25.0 
mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 1.00 equiv), and 
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xylene (5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the xylene was 
evaporated and the residue was purified by flash column chromatography using 1:50 
EtOAc:pentane as mobile phase to afford 2,6-diisopropylphenyl 3-oxobutanoate (25) as a colorless 
oil (5.00 g, 19.1 mmol, 76%). TLC (EtOAc:pentane, 1:20 v/v): Rf = 0.35, KMnO4; 1H NMR (400 
MHz, CDCl3): δ 12.08 (s, 0.22H, OH of enol form), 7.31–7.24 (m, 1H, ArH), 7.24–7.18 (m, 2H, 
ArH), 3.81 (s, 1.56H, CH3COCH2 of keto form), 3.03 (m, 2H, 2 X CH(CH3)2), 2.41 (s, 2.32H, 
CH3COCH2 of keto form), 1.28-1.21 (m, 12H, 2 X CH(CH3)2); 13C NMR (100 MHz, CDCl3): δ 
199.9, 165.7, 145.1, 140.2, 126.8, 124.0, 49.6, 30.4, 27.4, 27.3; Enol form, 13C NMR (100 MHz, 
CDCl3): δ 177.7, 171.5, 144.5, 140.5, 126.5, 123.9, 88.7, 23.7, 22.7, 21.4; IR ν 2966 (m), 2876 (w), 
1760 (m), 1723 (m), 1634 (w), 1447 (m), 1410 (w), 1360 (m), 1315 (m), 1222 (s), 1140 (s), 1102 
(m), 1053 (w), 976 (w); HRMS (ESI) calcd. for C16H22NaO3+ [M+Na]+ 285.1461; found 285.1467. 
 
Following a slightly modified procedure,1 to a solution of 2,6-diisopropylphenyl 3-oxobutanoate 
(25) (1.31 g, 5.00 mmol, 1.00 equiv) in acetonitrile (6 mL) was added triethylamine (660 mg, 6.50 
mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide 
(1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture was 
allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. 
The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The 
organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:30 
Et2O:pentane as mobile phase to afford 2,6-diisopropylphenyl 2-diazoacetate (1i) as a yellow oil 
(620 mg, 2.52 mmol, 50%). TLC (Et2O:pentane, 1:30 v/v): Rf = 0.36, KMnO4; 1H NMR (400 MHz, 
CDCl3): δ 7.32-7.25 (m, 1H, ArH), 7.23-7.20 (m, 2H, ArH), 5.09 (br s, 1H, CHN2), 3.05 (sept, J = 
6.9 Hz, 2H, 2 X CH(CH3)2), 1.27 (d, J = 6.9 Hz, 12H, 2 X CH(CH3)2); 13C NMR (100 MHz, 
CDCl3): δ 165.6, 145.1, 140.8, 126.7, 123.9, 46.3, 27.5, 23.4. The characterization data slightly 
differ from the reported values.5 
 




Following a slightly modified procedure,1 a mixture of 2,6-di-tert-butyl-4-methoxyphenol (26) 
(5.91 g, 25.0 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 
1.00 equiv), and xylene (5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, 
the xylene was evaporated and the residue was purified by flash column chromatography using 
1:30 EtOAc:pentane as mobile phase to afford 2,6-di-tert-butyl-4-methoxyphenyl 3-oxobutanoate 
(27) as a colorless thick oil (6.64 g, 20.0 mmol, 80%). Mp: 67.0–70.5 °C; TLC (EtOAc:pentane, 
1:15 v/v): Rf = 0.46, KMnO4; 1H NMR (400 MHz, CDCl3): δ 12.15 (s, 0.55H, OH of enol form), 
6.87 (s, 2H, ArH), 5.32 (s, 0.55H, vinyl H of enol form), 3.80 (s, 3H, ArOCH3), 3.73 (s, 0.9H, 
CH3COCH2 of keto form), 2.40 (s, 1.35H, CH3COCH2 of keto form), 2.07 (s, 1.65H, CH3 of enol 
form), 1.33 (s, 8.1H, C(CH3)3 of keto form), 1.32 (s, 9.9H, C(CH3)3 of enol form); 13C NMR (100 
MHz, CDCl3): δ 200.1, 167.9, 156.5, 143.3, 141.1, 111.7, 55.2, 50.6, 35.5, 31.3, 30.8; Enol form, 
13C NMR (100 MHz, CDCl3): δ 177.4, 173.5, 156.2, 143.6, 140.7, 111.5, 90.4, 55.2, 35.6, 31.2, 
21.5; IR ν 2966 (s), 2913 (s), 2118 (w), 1758 (m), 1724 (m), 1634 (s), 1596 (m), 1408 (s), 1310 
(m), 1223 (s), 1181 (s), 1143 (s), 1064 (s), 979 (w), 922 (w), 861 (w); HRMS (ESI) calcd. for 
C19H28NaO4+ [M+Na]+ 343.1880; found 343.1884. 
 
Following a slightly modified procedure,1 to a solution of 2,6-di-tert-butyl-4-methoxyphenyl 3-
oxobutanoate (27) (1.6 g, 5.0 mmol, 1.0 equiv) in acetonitrile (6 mL) was added triethylamine (660 
mg, 6.50 mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl 
azide (1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture 
was allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. 
The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The 
organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
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dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:20 
EtOAc:pentane as mobile phase to afford 2,6-di-tert-butyl-4-methoxyphenyl 2-diazoacetate (1j) as 
a yellow solid (600 mg, 1.97 mmol, 40%). Mp (Dec.): 125.3–130.0 °C; TLC (EtOAc:pentane, 1:15 
v/v): Rf = 0.31, KMnO4; 1H NMR (400 MHz, CDCl3): δ 6.86 (s, 2H, ArH), 5.01 (s, 1H, CHN2), 
3.80 (s, 3H, ArOCH3), 1.36 (s, 18H, 2 X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 166.8, 156.4, 
143.9, 141.0, 111.6, 55.2, 47.4, 35.6, 31.4; IR ν 3105 (w), 2961 (m), 2114 (s), 1712 (s), 1593 (m), 
1427 (w), 1365 (s), 1180 (s), 1149 (s), 1103 (w), 1064 (m), 919 (w), 862 (w); HRMS (ESI) calcd. 
for C17H24N2NaO3+ [M+Na]+ 327.1679; found 327.1679. 
 
2,6-Di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) 
 
Following a slightly modified procedure,1 a mixture of 2,6-di-tert-butyl-4-methylphenol (28) (5.91 
g, 25.0 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (3.55 g, 25.0 mmol, 1.00 
equiv), and xylene (5 mL) was stirred at 140 °C for 2 h. After cooling to room temperature, the 
xylene was evaporated and the residue was purified by flash column chromatography using 1:50 
EtOAc:pentane as mobile phase to afford 2,6-di-tert-butyl-4-methylphenyl 3-oxobutanoate (29) as 
a white solid (6.40 g, 21.0 mmol, 84%). Mp: 96.5–99.6 °C; TLC (EtOAc:pentane, 1:50 v/v): Rf = 
0.34, KMnO4; 1H NMR (400 MHz, CDCl3): 12.16 (s, 0.55H, OH of enol form), δ 7.13 (s, 2H, 
ArH), 5.39–5.24 (m, 0.55H, vinyl H of enol form), 3.73 (s, 1H, 0.9H, CH3COCH2 of keto form), 
2.40 (s, 1H, 1.35H, CH3COCH2 of keto form), 2.33 (s, 3H, ArCH3), 2.07 (s, 1.65H, CH3 of enol 
form), 1.33 (s, 8.1H, C(CH3)3 of keto form), 1.32 (s, 9.9H, C(CH3)3 of enol form); 13C NMR (100 
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MHz, CDCl3): δ 200.2, 167.7, 145.3, 141.8, 135.0, 127.2, 50.7, 35.2, 31.4, 30.8, 21.5; Enol form, 
13C NMR (100 MHz, CDCl3): δ 177.4, 173.3, 144.9, 142.2, 134.6, 126.9, 90.4, 35.2, 31.4, 21.5, 
21.5; IR ν 2964 (m), 2919 (m), 2880 (w), 2110 (w), 1757 (m), 1726 (m), 1633 (s), 1408 (m), 1369 
(m), 1318 (m), 1219 (s), 1199 (s), 1143 (s), 1113 (m), 1030 (w), 978 (w), 924 (w); HRMS (ESI) 
calcd. for C19H28NaO3+ [M+Na]+ 327.1931; found 327.1933. 
 
Following a slightly modified procedure,1 to a solution of 2,6-di-tert-butyl-4-methylphenyl 3-
oxobutanoate (29) (1.52 g, 5.00 mmol, 1.00 equiv) in acetonitrile (6 mL) was added triethylamine 
(660 mg, 6.50 mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of 
tosyl azide (1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction 
mixture was allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced 
pressure. The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. 
The organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. The crude product was purified by column chromatography using 1:30 
Et2O:pentane as mobile phase to afford 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) as a 
yellow solid (1.20 g, 4.16 mmol, 83%). TLC (Et2O:pentane, 1:30 v/v): Rf = 0.36, KMnO4; 1H NMR 
(400 MHz, CDCl3): δ 7.12 (s, 2H, ArH), 5.00 (s, 1H, CHN2), 2.32 (s, 3H, ArCH3), 1.36 (s, 18H, 2 
X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 166.3, 145.1, 142.4, 134.8, 127.0, 47.3, 35.3, 31.5, 
21.5. The 1H NMR data corresponded to the reported values.4  
 
Ethyl diazomethanesulfonate (1l) 
 
Following a reported procedure,6 to a solution of ethyl methanesulfonate (30) (1.86 g, 15.0 mmol, 
1.00 equiv) in dry THF (50 mL) was added a 1 M LiHMDS solution in hexane (18 mL, 18 mmol, 
1.2 equiv) at -78 °C. After stirring the reaction mixture for 30 min at this temperature, 2,2,2-
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trifluoroethyl trifluoroacetate (2.4 mL, 18 mmol, 1.2 equiv) was added rapidly in one portion via 
syringe. After 10 min, the reaction mixture was poured into a solution of diethyl ether (20 mL) and 
5% HCl (50 mL). The mixture was extracted with diethyl ether (3 x 50 mL), washed with brine (50 
mL), dried over MgSO4, filtered and concentrated under reduced pressure to give a yellow oil 31. 
This yellow oil was immediately dissolved in dry CH3CN (30 mL). To this solution was added p-
acetamidobenzenesulfonyl azide (4.32 g, 18.0 mmol, 1.20 equiv), Et3N (2.5 mL, 18 mmol, 1.2 
equiv), and water (0.27 mL, 15 mmol, 1.0 equiv). After stirring the reaction mixture overnight at 
room temperature, the solvent was removed under reduced pressure and the residue was filtered on 
short silica gel and washed with a mixture of ethyl acetate (100 mL) and hexane (100 mL). The 
filtrate was concentrated under vacuum and the residue was purified by flash column 
chromatography using 1:10 EtOAc:pentane as mobile phase to afford ethyl diazomethanesulfonate 
(1l) as a yellow oil (0.9 g, 6 mmol, 40%). TLC (EtOAc:pentane, 1:10 v/v): Rf = 0.25, KMnO4; 1H 
NMR (400 MHz, CDCl3): δ 5.25 (s, 1H, CHN2), 4.26 (q, J = 7.1 Hz, 2H, CH2CH3), 1.41 (t, J = 7.1 
Hz, 3H, CH2CH3); 13C NMR (100 MHz, CDCl3): δ 67.4, 52.4, 14.6. The characterization data 
corresponded to the reported values.6 
 
Diethyl (diazomethyl)phosphonate (1m) 
 
Following a reported procedure,7 a mixture of diethyl (2-oxopropyl)phosphonate (32) (1.15 mL, 
6.00 mmol, 1.00 equiv), tosyl azide (1.3 g, 6.6 mmol, 1.1 equiv) and triethylamine (6 mL) was 
stirred at room temperature for 18 h. After evaporation of triethylamine under reduced pressure, 
the residue was dissolved in diethyl ether (50 mL). The precipitate was filtered off, the filtrate was 
evaporated and the residue was purified by column chromatography using 1:1 EtOAc:pentane as 
mobile phase to afford diethyl (1-diazo-2-oxopropyl)phosphonate (33) as a yellow oil (810 mg, 
3.68 mmol, 61%). TLC (EtOAc:pentane, 1:4 v/v): Rf = 0.49, KMnO4; 1H NMR (400 MHz, CDCl3): 
δ 4.04– 4.19 (m, 4H, 2 X CH2CH3) 2.19 (s, 3H, CH3), 1.30 (t, J = 7.0 Hz, 6H, 2 X CH2CH3); 13C 
NMR (100 MHz, CDCl3): 190.1 (d, J = 13.2 Hz), 63.4 (d, J = 5.6 Hz), 27.1, 16.0 (d, J = 6.8 Hz). 




To a solution of diethyl (1-diazo-2-oxopropyl)phosphonate (33) (694 mg, 3.15 mmol, 1.00 equiv) 
in MeOH (9 mL) was added Na2CO3 (401 mg, 3.78 mmol, 1.20 equiv). The mixture was stirred at 
room temperature for 15 min. The precipitate was filtered off, the filtrate was evaporated and the 
residue was purified by column chromatography using 1:1 EtOAc:pentane as mobile phase to 
afford diethyl (diazomethyl)phosphonate (1m) as a yellow oil (533 mg, 2.99 mmol, 95%). TLC 
(EtOAc:pentane, 1:4 v/v): Rf = 0.41, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.17–4.08 (m, 4H, 2 
X CH2CH3), 3.75 (d, J = 11.1 Hz, 1H, CHN2), 1.34 (td, J = 7.1, 0.7 Hz, 6H, 2 X CH2CH3); 13C 
NMR (100 MHz, CDCl3): δ 62.6 (d, J = 5.3 Hz), 16.1 (d, J = 6.9 Hz). One carbon was not resolved 
at 100 MHz. The characterization data corresponded to the reported values.8 
2-Diazo-N-methoxy-N-methylacetamide (1n) 
 
Following a reported procedure,9 a mixture of N,O-dimethylhydroxylamine hydrochloride (34) 
(2.44 g, 25.0 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one (14) (5.00 mL, 37.5 mmol, 
1.50 equiv) and triethylamine (3.85 mL, 27.5 mmol, 1.10 equiv) was dissolved in toluene (75 mL) 
and refluxed for 2 h. The reaction mixture was cooled to room temperature and washed with 
aqueous hydrochloric acid (90 mL, 1.0 M) and the aqueous layer was extracted with ethyl acetate 
(3 x 100 mL). The combined organic layers were dried over MgSO4 and the solvent was evaporated 
under reduced pressure. The crude product was purified by flash column chromatography using 
1:1 EtOAc:pentane as mobile phase to afford N-methoxy-N-methyl-3-oxobutanamide (35) as a 
yellow oil (2.40 g, 16.5 mmol, 66%). TLC (EtOAc:pentane, 1:1 v/v): Rf = 0.26, KMnO4; 1H NMR 
(400 MHz, CDCl3): δ 13.65 (s, 0.13H, OH of enol form), 5.32 (s, 0.13H, vinyl H of enol form) 
3.60 (s, 3H, OCH3), 3.50 (s, 1.74H, CH3COCH2 of keto form), 3.13 (s, 2.6H, N-CH3 of keto form), 
3.11 (s, 0.4H, enol form of N-CH3), 2.17 (s, 2.6H, CH3COCH2 of keto form), 1.89 (s, 0.4H, enol 
form of CH3); 13C NMR (100 MHz, CDCl3): δ 201.7, 167.8, 61.1, 48.3, 31.8, 30.0; Enol form, 13C 
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NMR (100 MHz, CDCl3): δ 175.0, 172.2, 86.5, 21.6. Two carbons were not resolved at 100 MHz. 
The characterization data corresponded to the reported values.9 
 
Following a slightly modified procedure,1 to a solution of N-methoxy-N-methyl-3-oxobutanamide 
(35) (0.73 g, 5.0 mmol, 1.0 equiv) in acetonitrile (6 mL) was added triethylamine (660 mg, 6.50 
mmol, 1.30 equiv). The reaction mixture was cooled in an ice bath and a solution of tosyl azide 
(1.1 g, 5.5 mmol, 1.1 equiv) in acetonitrile (6 mL) was added slowly. The reaction mixture was 
allowed to warm to r.t. After stirring for 20 h, the solvent was removed under reduced pressure. 
The residue was dissolved in ether (30 mL) and washed with 8% aqueous KOH solution. The 
organic layer was separated, dried over MgSO4, and evaporated. The crude product was re-
dissolved in acetonitrile (15 mL) and 8% aqueous KOH (25 mL) solution was added at r.t. After 
vigorous stirring for 4 h, water (15 mL) was added and the reaction mixture was extracted with 
diethyl ether (2 X 30 mL). The combined organic layers were dried over MgSO4, and concentrated 
under reduced pressure. Purification by column chromatography using 1:1 EtOAc:pentane as 
mobile phase to afford 2-diazo-N-methoxy-N-methylacetamide (1n) as a yellow liquid (350 mg, 
2.71 mmol, 54%). TLC (EtOAc:pentane, 1:1 v/v): Rf = 0.27, KMnO4; 1H NMR (400 MHz, CDCl3): 
δ 5.30 (s, 1H, CHN2), 3.60 (s, 3H, OCH3), 3.12 (s, 3H, CH3);13C NMR (100 MHz, CDCl3): δ 168.1, 
61.3, 46.1, 33.0. The values of the NMR spectra are in accordance with reported literature data.10 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 2-diazoacetate (1o) 
 
Following a slightly modified procedure,1 a mixture of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexanol (36) (1.95 g, 12.5 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one 
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(14) (1.78 g, 12.5 mmol, 1.00 equiv), and xylene (2.5 mL) was stirred at 140 °C for 2 h. After 
cooling to room temperature, the xylene was evaporated and the residue was purified by flash 
column chromatography using 1:50 EtOAc:pentane as mobile phase to afford (1R,2S,5R)-2-
isopropyl-5-methylcyclohexyl 3-oxobutanoate (37) as a colorless liquid (1.70 g, 7.07 mmol, 57%). 
TLC (EtOAc:pentane, 1:25 v/v): Rf = 0.3, KMnO4; 1H NMR (400 MHz, CDCl3): δ 12.18 (s, 0.08H, 
OH of enol form), 4.94 (s, 0.08H, vinyl H of enol form), 4.71 (td, J = 10.9, 4.4 Hz, 1H, OCH), 3.41 
(s, 1.84H, CH3COCH2 of keto form), 2.24 (s, 2.75H, CH3COCH2 of keto form), 2.04-1.95 (m, 1H), 
1.93 (s, 0.025H, CH3 of enol form), 1.90-1.79 (m, 1H), 1.71–1.61 (m, 2H), 1.54-1.40 (m, 1H), 1.39-
1.29 (m, 1H), 1.10–0.92 (m, 2H), 0.91-0.83 (m, 7H), 0.74 (d, J = 7.0 Hz, 3H, CH3); 13C NMR (100 
MHz, CDCl3): δ 200.7, 166.7, 75.4, 50.5, 46.7, 40.6, 34.0, 31.3, 30.0, 26.0, 23.1, 21.9, 20.7, 16.0; 
Enol form, 13C NMR (100 MHz, CDCl3): δ 175.2, 172.3, 90.0, 73.6, 46.9, 40.9, 34.1, 26.2, 23.4, 
22.0, 21.2, 20.6, 16.3. One carbon of enol form was not resolved at 100 MHz. The 1H NMR data 
corresponded to the reported values.11 
 
Following a slightly modified procedure,11 to a solution of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl 3-oxobutanoate (37) (0.72 g, 3.0 mmol, 1.0 equiv) in acetonitrile (3.0 mL) was 
added triethylamine (0.33 g, 3.3 mmol, 1.1 equiv). The reaction mixture was cooled in an ice bath 
and a solution of tosyl azide (0.77 g, 3.9 mmol, 1.3 equiv) in acetonitrile (3.0 mL) was added 
slowly. The reaction mixture was allowed to warm to r.t. After stirring for 6 h, the reaction mixture 
was treated with a solution of LiOH·H2O (0.38 g, 9.0 mmol, 3.0 equiv) in water (3 mL) and stirred 
for another 6 h. The resulting mixture was extracted with diethyl ether (2 × 15 mL). The combined 
organic layers were washed with brine (15 mL) and dried over anhydrous MgSO4. The solvent was 
removed under reduced pressure, and the residue was purified by silica gel column chromatography 
using 1:30 Et2O:pentane as mobile phase to afford (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-
diazoacetate (1o) as a yellow solid (0.60 g, 2.7 mmol, 89%). TLC (Et2O:pentane, 1:30 v/v): Rf = 
0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.80-4.67 (m, 2H, CHN2 and OCH), 2.10–1.96 (m, 
1H), 1.93-1.79 (m, 1H), 1.73–1.60 (m, 2H), 1.56-1.42 (m, 1H), 1.40-1.30 (m, 1H), 1.12–0.93 (m, 
2H), 0.92-0.86 (m, 7H), 0.77 (d, J = 7.0 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3): δ 166.6, 74.7, 
47.1, 46.2, 41.2, 34.1, 31.4, 26.3, 23.5, 22.0, 20.7, 16.4. The characterization data corresponded to 




(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-diazoacetate (1p) 
 
Following a slightly modified procedure,1 a mixture of (1S,2R,5S)-2-isopropyl-5-
methylcyclohexanol (38) (1.95 g, 12.5 mmol, 1.00 equiv), 2,2,6-trimethyl-4H-1,3-dioxin-4-one 
(14) (1.78 g, 12.5 mmol, 1.00 equiv), and xylene (2.5 mL) was stirred at 140 °C for 2 h. After 
cooling to room temperature, the xylene was evaporated and the residue was purified by flash 
column chromatography using 1:50 EtOAc:pentane as mobile phase to afford (1S,2R,5S)-2-
isopropyl-5-methylcyclohexyl 3-oxobutanoate (39) as a white solid (1.90 g, 7.91 mmol, 63%). TLC 
(EtOAc:pentane, 1:25 v/v): Rf = 0.3, KMnO4; 1H NMR (400 MHz, CDCl3): δ 12.18 (s, 0.08H, OH 
of enol form), 4.94 (s, 0.08H, vinyl H of enol form), 4.72 (td, J = 10.9, 4.4 Hz, 1H, OCH), 3.42 (s, 
1.84H, CH3COCH2 of keto form), 2.25 (s, 2.76H, CH3COCH2 of keto form), 2.05-1.95 (m, 1H), 
1.93 (s, 0.025H, CH3 of enol form), 1.90-1.79 (m, 1H), 1.72–1.60 (m, 2H), 1.54-1.41 (m, 1H), 1.40-
1.31 (m, 1H), 1.13–0.91 (m, 2H), 0.92-0.84 (m, 7H), 0.75 (d, J = 7.0 Hz, 3H, CH3); 13C NMR (100 
MHz, CDCl3): δ 200.7, 166.7, 75.4, 50.5, 46.8, 40.6, 34.1, 31.3, 30.0, 26.0, 23.1, 21.9, 20.7, 16.0; 
Enol form, 13C NMR (100 MHz, CDCl3): δ 175.2, 172.3, 90.0, 73.6, 46.9, 40.9, 34.1, 26.2, 23.4, 
22.0, 21.2, 20.6, 16.3. One carbon of enol form was not resolved at 100 MHz. The characterization 
data corresponded to the reported values.13 
 
Following a slightly modified procedure,11 to a solution of (1S,2R,5S)-2-isopropyl-5-
methylcyclohexyl 3-oxobutanoate (39) (0.72 g, 3.0 mmol, 1.0 equiv) in acetonitrile (3.0 mL) was 
added triethylamine (0.33 g, 3.3 mmol, 1.1 equiv). The reaction mixture was cooled in an ice bath 
and a solution of tosyl azide (0.77 g, 3.9 mmol, 1.3 equiv) in acetonitrile (3.0 mL) was added 
slowly. The reaction mixture was allowed to warm to r.t. After stirring for 6 h, the reaction mixture 
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was treated with a solution of LiOH·H2O (0.38 g, 9.0 mmol, 3.0 equiv) in water (3 mL) and stirred 
for another 6 h. The resulting mixture was extracted with diethyl ether (2 × 15 mL). The combined 
organic layers were washed with brine (15 mL) and dried over anhydrous MgSO4. The solvent was 
removed under reduced pressure, and the residue was purified by silica gel column chromatography 
using 1:30 Et2O:pentane as mobile phase to afford (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-
diazoacetate (1p) as a yellow solid (500 mg, 2.23 mmol, 74%). TLC (Et2O:pentane, 1:30 v/v): Rf 
= 0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.74 (m, 2H, CHN2 and OCH), 2.06-1.98 (m, 1H), 
1.92-1.81 (m, 1H), 1.73–1.61 (m, 2H), 1.56-1.41 (m, 1H), 1.40-1.30 (m, 1H), 1.13–0.92 (m, 2H), 
0.92-0.86 (m, 7H), 0.77 (d, J = 6.9 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3): δ 166.5, 74.7, 47.1, 




tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl 2-diazoacetate (1q) 
 
Following reported procedure,15 dehydroepiandrosterone 40 (1.16 g, 4.00 mmol. 1.00 equiv) and 
NaHCO3 (1.6 g, 20 mmol, 5.0 equiv) were dissolved in dry CH2Cl2 (20 mL) and bromoacetyl 
bromide (0.7 mL, 8 mmol, 2 equiv) was added slowly at 0 °C and the reaction mixture was stirred 
for 6 h at room temperature. The reaction was then quenched with water (50 mL) and the solution 
was extracted with CH2Cl2 (3 x 100 mL). After washing with water (100 mL) and drying over 
MgSO4, the solvent was evaporated and the residue was used in the next step without further 
purification. The resulting crude bromoacetamide 41 and N,N′-ditosylhydrazine (2.72 g, 8.00 
mmol, 2.00 equiv) were dissolved in dry THF (20 mL) and cooled down to 0 ˚C, then DBU (3.0 
mL, 20 mmol, 5.0 equiv) was added dropwise and stirred at room temperature for 1 h. After 
quenching with saturated solution of NaHCO3 (40 mL) and extracting with diethyl ether (3 X 100 
mL), the organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The resulting 
crude product was purified by flash chromatography using EtOAc:pentane 1:5 as mobile phase to 
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afford 1q (1.1 g, 3.1 mmol, 77%) as a pale yellow solid. Mp (Dec.): 192.3–196.8 °C; TLC 
(EtOAc:pentane, 1:5 v/v): Rf = 0.42, KMnO4; 1H NMR (400 MHz, CDCl3): δ 5.41 (d, J = 5.0 Hz, 
1H, olefinic H), 4.84–4.54 (m, 2H, N2CH and OCH), 2.56–2.24 (m, 3H), 2.17–2.02 (m, 2H), 2.00–
1.78 (m, 4H), 1.74–1.41 (m, 6H), 1.34–1.22 (m, 2H), 1.16 (td, J = 13.9, 13.2, 4.2 Hz, 1H), 1.08–
0.97 (m, 4H), 0.88 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 221.0, 166.3, 139.8, 122.0, 75.0, 51.6, 
50.1, 47.5, 46.3, 38.2, 36.9, 36.7, 35.8, 31.4, 31.4, 30.7, 27.9, 21.8, 20.3, 19.3, 13.5. The 






Following a reported procedure,15 cholesterol 42 (773 mg, 2.00 mmol, 1.00 equiv) and NaHCO3 
(840 mg, 10.0 mmol, 5.00 equiv) were dissolved in dry CH2Cl2 (10 mL) and bromoacetyl bromide 
(0.53 mL, 6.0 mmol, 3.0 equiv) was added slowly at 0 °C and stirred for 6 h at room temperature, 
the reaction was quenched with H2O (25 mL) and the solution was extracted with CH2Cl2 (3 x 50 
mL). After washing with water (50 mL) and drying over MgSO4, the solvent was evaporated and 
the residue was used in the next step without further purification. The resulting crude 
bromoacetamide 43 and N,N′-ditosylhydrazine (1.36 g, 4.00 mmol, 2.00 equiv) were dissolved in 
dry THF (10 mL) and cooled down to 0 ˚C, then DBU (1.5 mL, 10 mmol, 5.0 equiv) was added 
dropwise and stirred at room temperature for 1 h. After quenching with saturated solution of 
NaHCO3 (20 mL) and extracting with diethyl ether (3 x 50 mL), the organic layer was dried over 
MgSO4, filtered and concentrated in vacuo. The resulting crude product was purified by flash 
chromatography using Et2O:pentane 1:20 as mobile phase to afford 1r (750 mg, 1.65 mmol, 82%) 
as a pale yellow solid. TLC (Et2O:pentane, 1:20 v/v): Rf = 0.4, KMnO4; 1H NMR (400 MHz, 
CDCl3): δ 5.38 (d, J = 5.1 Hz, 1H, olefinic H), 4.75–4.65 (m, 2H, N2CH and OCH), 2.45–2.23 (m, 
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2H), 2.08–1.76 (m, 5H), 1.64–0.80 (m, 33H), 0.68 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 166.3, 
139.5, 122.8, 74.6, 56.7, 56.1, 50.0, 46.3, 42.3, 39.7, 39.5, 38.3, 36.9, 36.5, 36.2, 35.8, 31.9, 31.8, 
28.2, 28.0, 28.0, 24.3, 23.8, 22.8, 22.5, 21.0, 19.3, 18.7, 11.8. The characterization data 





3. Preparation of EBX reagents  
The synthesis of R-EBX reagents 2a-2p except 2e had been already described before. The 
procedures are taken here from the indicated publications to facilitate reproduction of the results 




Following a reported procedure,16 NaIO4 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-iodobenzoic acid 
(44) (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH (48 mL). The mixture 
was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with cold water 
(180 mL) and allowed to cool to room temperature, protecting it from light. After 1 h, the crude 
product was collected by filtration, washed on the filter with ice water (3 x 20 mL) and acetone (3 
x 20 mL), and air-dried in the dark to give the pure product 45 (8.3 g, 31 mmol, 98%) as a white 
solid. 1H NMR (400 MHz, (CD3)2SO): δ 8.02 (dd, J = 7.7, 1.4 Hz, 1H, ArH), 7.97 (m, 1H, ArH), 
7.85 (dd, J = 8.2, 0.7 Hz, 1H, ArH), 7.71 (td, J = 7.6, 1.2 Hz, 1H, ArH); 13C NMR (100 MHz, 
(CD3)2SO): δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4; IR ν 3083 (w), 3060 (w), 2867 (w), 
2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 (m), 1018 (w), 834 
(m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m). The values of the NMR spectra are in accordance 
with reported literature data.16 
Triisopropylsilyl trimethylsilylacetylene (47) 
 
Following a reported procedure,17 BuLi (2.5 M in hexanes, 12.0 mL, 29.9 mmol, 0.98 equiv) was 
added dropwise to a stirred solution of ethynyltrimethylsilane (46) (3.0 g, 30 mmol, 1.0 equiv) in 
THF (48 mL) at -78 °C. The mixture was then warmed to 0 °C and stirred for 5 min. The mixture 
was then cooled back to -78 °C and chlorotriisopropylsilane (6.4 mL, 30 mmol, 1.0 equiv) was 
added dropwise. The mixture was then allowed to warm to room temperature and stirred overnight. 
S23 
 
A saturated solution of ammonium chloride (40 mL) was added, and the reaction mixture was 
extracted with diethyl ether (2 x 60 mL). The organic layer was washed with water and brine, then 
dried over MgSO4, filtered and concentrated under reduced pressure to obtain a colorless liquid 
which was further purified by Kugelrohr distillation (56-57 °C/0.25 mm of Hg) to yield 47 (7.16 
g, 28.0 mmol, 92% yield) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 1.08 (m, 21H, TIPS), 
0.18 (s, 9H, TMS); IR ν 2959 (m), 2944 (m), 2896 (w), 2867 (m), 1464 (w), 1385 (w), 1250 (m), 
996 (w), 842 (s), 764 (s), 675 (m), 660 (m). The values of the NMR spectra are in accordance with 




Following a reported procedure,18 2-iodosylbenzoic acid (45) (21.7 g, 82.0 mmol, 1.00 equiv) was 
charged in oven-dried three-neck 1L flask equipped with a magnetic stirrer. After 3 
vacuum/nitrogen cycles, anhydrous acetonitrile (500 mL) was added via canula and cooled to 0 °C. 
Trimethylsilyltriflate (16.4 mL, 90.0 mmol, 1.10 equiv) was added dropwise via a dropping funnel 
over 30 min (no temperature increase was observed). After 15 min, 
(trimethylsilyl)(triisopropylsilyl)acetylene (47) (23.0 g, 90.0 mmol, 1.10 equiv) was added via 
canula over 15 min (no temperature increase was observed). After 30 min, the suspension became 
an orange solution. After 10 min, pyridine (7.0 mL, 90 mmol, 1.1 equiv) was added via syringe. 
After 15 min, the reaction mixture was transferred in a one-neck 1L flask and reduced under 
vacuum until a solid was obtained. The solid was dissolved in CH2Cl2 (200 mL) and transferred in 
a 1L separatory funnel. The organic layer was added and washed with 1 M HCl (200 mL) and the 
aqueous layer was extracted with CH2Cl2 (200 mL). The organic layers were combined, washed 
with a saturated solution of NaHCO3 (2 x 200 mL), dried over MgSO4, filtered and the solvent was 
evaporated under reduced pressure. Recrystallization from acetonitrile (ca 120 mL) afforded 2a 
(30.1 g, 70.2 mmol, 86%) as colorless crystals. Mp (Dec.): 170.0-176.0 °C; 1H NMR (400 MHz, 
CDCl3): δ 8.44 (m, 1H, ArH), 8.29 (m, 1H, ArH), 7.77 (m, 2H, ArH), 1.16 (m, 21H, TIPS); 13C 
NMR (100 MHz, CDCl3): δ 166.4, 134.6, 132.3, 131.4, 131.4, 126.1, 115.6, 114.1, 64.6, 18.4, 11.1; 
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IR ν 2943 (m), 2865 (m), 1716 (m), 1618 (m), 1604 (s), 1584 (m), 1557 (m), 1465 (m), 1439 (w), 
1349 (m), 1291 (m), 1270 (w), 1244 (m), 1140 (m), 1016 (m), 999 (m), 883 (m), 833 (m), 742 (m), 
702 (s), 636 (m). The characterization data corresponded to the reported values.18  
 
5-Methyl-2-iodosylbenzoic acid (49) 
 
Following a reported procedure,19 NaIO4 (1.25 g, 5.84 mmol, 1.05 equiv) and 2-iodo-5-
methylbenzoic acid (48) (1.46 g, 5.56 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH 
(15 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then 
diluted with cold water (40 mL) and allowed to cool to room temperature, protecting it from light. 
The crude product was collected by filtration, washed on the filter with ice water (3 x 4 mL) and 
acetone (3 x 4 mL), and air-dried in the dark to give the pure product 49 (1.39 g, 5.00 mmol, 90%) 
as a colorless solid. 1H NMR (400 MHz, (CD3)2SO): δ 7.84 (s, 1H, ArH), 7.78 (m, 1H, ArH), 7.69 





Following a reported procedure,19 trimethylsilyltriflate (400 μL, 2.20 mmol, 1.10 equiv) was added 
dropwise to a stirred solution of 49 (556 mg, 2.00 mmol, 1.00 equiv) in acetonitrile (10 mL). After 
20 min, (trimethylsilyl)(triiso-propylsilyl)acetylene (47) (560 mg, 2.20 mmol, 1.10 equiv) was then 
added dropwise, followed, after 20 min, by the addition of pyridine (180 μL, 2.20 mmol, 1.10 
equiv). The mixture was stirred for 20 min. The solvent was then removed under reduced pressure 
and the yellow crude oil was dissolved in CH2Cl2 (20 mL). The organic layer was washed with 1 
M HCl (20 mL) and the aqueous layer was extracted with CH2Cl2 (20 mL). The organic layers 
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were combined, washed with a saturated solution of NaHCO3 (40 mL), dried over MgSO4, filtered 
and the solvent was evaporated under reduced pressure. Recrystallization from acetonitrile (ca 25 
mL) and wash with hexanes afforded 2b (559 mg, 1.26 mmol, 63%) as colorless crystals. Mp 
(Dec.): 192.0-197.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.23 (d, J = 1.5 Hz, 1H, ArH), 8.12 (d, J = 
8.5 Hz, 1H, ArH), 7.57 (dd, J = 8.5, 1.8 Hz, 1H, ArH), 2.51 (s, 3H, ArCH3), 1.16 (m, 21H, TIPS); 
13C NMR (100 MHz, CDCl3): δ 166.6, 142.5, 135.6, 133.0, 131.2, 125.8, 113.8, 111.8, 64.6, 20.7, 
18.5, 11.2. The characterization data corresponded to the reported values.19 
  
3-Methyl-2-iodosylbenzoic acid (51) 
 
Following a reported procedure,19 NaIO4 (1.25 g, 5.84 mmol, 1.05 equiv) and 2-iodo-3-
methylbenzoic acid (50) (1.46 g, 5.56 mmol, 1.00 equiv) were suspended in 30% (v:v) aq. AcOH 
(15 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then 
diluted with cold water (40 mL) and allowed to cool to RT, protecting it from light. The crude 
product was collected by filtration, washed on the filter with ice water (3 x 4 mL) and acetone (3 x 
4 mL), and air-dried in the dark to give the pure product 51 (1.24 g, 4.46 mmol, 80%) as a white 
solid. 1H NMR (400 MHz, DMSO) δ 8.30 (br s, 1 H, OH), 7.85 (m, 1 H, ArH), 7.57 (m, 2 H, ArH), 




Following a reported procedure,19 trimethylsilyltriflate (2.10 mL, 11.6 mmol, 1.1 equiv) was added 
dropwise to a stirred solution of 51 (2.93 g, 10.5 mmol, 1.0 equiv) in acetonitrile (45 mL). After 
20 min, (trimethylsilyl)(triiso-propylsilyl)acetylene (47) (2.94 g, 11.6 mmol, 1.1 equiv) was then 
added dropwise, followed, after 30 min, by the addition of pyridine (934 μL, 11.6 mmol, 1.1 equiv). 
The mixture was stirred 20 min. The solvent was then removed under reduced pressure and the 
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yellow crude oil was dissolved in dichloromethane (30 mL). The organic layer was washed with 1 
M HCl (20 mL) and the aqueous layer was extracted with CH2Cl2 (30 mL). The organic layers 
were combined, washed with a saturated solution of NaHCO3 (40 mL), dried over MgSO4, filtered 
and the solvent was evaporated under reduced pressure. Recrystallization from acetonitrile (ca 10 
mL) and wash with pentane afforded 2c (2.79 g, 6.31 mmol, 60 %) as colorless cristals. Mp (Dec.): 
138.0–145.0 °C; 1H NMR (400 MHz, CDCl3); δ 8.21 (dd, 1H, J = 6.8, 2.5 Hz, ArH), 7.50 (m, 2H, 
ArH), 2.87 (s, 3H, CH3), 1.10 (m, 21H, TIPS); 13C NMR (100 MHz, CDCl3) δ 166.8, 140.3, 138.0, 
133.3, 131.7, 130.8, 119.1, 112.5, 66.9, 24.0, 18.5, 11.2; IR 2946 (w), 2867 (w), 2244 (w), 1649 
(m), 1562 (w), 1464 (w), 1326 (w), 1281 (w), 998 (w), 907 (s), 884 (w), 763 (w), 728 (s), 687 (s), 
647 (m). The characterization data corresponded to the reported values.19 
 
5-Fluoro-2-iodosylbenzoic acid (53) 
 
Following a reported procedure,19 NaIO4 (656 mg, 3.07 mmol, 1.05 equiv) and 2-iodo-4-
fluorobenzoic acid (52) (778 mg, 2.92 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH 
(7 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then 
diluted with cold water (20 mL) and allowed to cool to room temperature, protecting it from light. 
The crude product was collected by filtration, washed on the filter with ice water (3 x 4 mL) and 
acetone (3 x 4 mL), and air-dried in the dark to give the pure product 53 (738 mg, 2.62 mmol, 90%) 
as a white solid. 1H NMR (400 MHz, (CD3)2SO): δ 7.88-7.79 (m, 3H, ArH and OH), 7.75 (m, 1H, 






Following a reported procedure,19 trimethylsilyltriflate (247 μL, 1.36 mmol, 1.10 equiv, freshly 
distilled) was added dropwise to a stirred solution of 53 (350 mg, 1.24 mmol, 1.00 equiv) in 
acetonitrile (5 mL). (Trimethylsilyl)(triiso-propylsilyl)acetylene (47) (349 mg, 1.36 mmol, 1.10 
equiv) was then added dropwise, followed, after 15 min, by the addition of pyridine (110 μL, 1.36 
mmol, 1.10 equiv). The mixture was stirred for 10 min. The solvent was then removed under 
reduced pressure and the yellow crude oil was dissolved in CH2Cl2 (50 mL). The organic layer was 
washed with 1 M HCl (50 mL) and the aqueous layer was extracted with CH2Cl2 (50 mL). The 
organic layers were combined, washed with a saturated solution of NaHCO3 (2 x 50 mL), dried 
over MgSO4, filtered and the solvent was evaporated under reduced pressure. Recrystallization 
from acetonitrile (ca 5 mL) afforded 2d (381 mg, 0.854 mmol, 69%) as a white solid. Mp (Dec.); 
185.0-189.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.22 (dd, J = 9.0, 4.2 Hz, 1H, ArH), 8.10 (dd, J = 
7.9, 2.9 Hz, 1H, ArH), 7.48 (m, 1H, ArH), 1.16 (m, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 
165.6 (d, J = 254 Hz), 165.2 (d, J = 7 Hz), 134.2 (d, J = 7 Hz), 127.8 (d, J = 8 Hz), 122.2 (d, J = 
24 Hz), 119.4 (d, J = 24 Hz), 115.0, 108.0 (d, J = 1 Hz), 64.0, 18.5, 11.2. The characterization data 
corresponded to the reported values.19  
 
6-Fluoro-2-iodosylbenzoic acid (55) 
 
Following a slightly modified procedure,19 NaIO4 (656 mg, 3.07 mmol, 1.05 equiv) and 2-iodo-6-
fluorobenzoic acid (54) (778 mg, 2.92 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH 
(7 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then 
diluted with cold water (20 mL) and allowed to cool to room temperature, protecting it from light. 
The crude product was collected by filtration, washed on the filter with ice water (3 x 4 mL) and 
acetone (3 x 4 mL), and air-dried in the dark to give the pure product 55 (738 mg, 2.62 mmol, 90%) 
as a white solid. 1H NMR (400 MHz, (CD3)2SO): δ 8.21 (s, 1H, OH), 7.89 (td, J = 8.1, 4.6 Hz, 1H, 
ArH), 7.70 (d, J = 8.1 Hz, 1H, ArH), 7.53 (dd, J = 10.3, 8.1 Hz, 1H, ArH); 13C NMR (100 MHz, 
CDCl3): δ 163.9 (d, J = 263.9 Hz), 163.9 (d, J = 4.4 Hz), 135.3 (d, J = 8.6 Hz), 123.3, 122.6 (d, J 
= 3.9 Hz), 119.3 (d, J = 12.0 Hz), 118.7 (d, J = 21.8 Hz). The characterization data corresponded 





Trimethylsilyltriflate (247 μL, 1.36 mmol, 1.10 equiv, freshly distilled) was added dropwise to a 
stirred solution of 55 (350 mg, 1.24 mmol, 1.00 equiv) in acetonitrile (5 mL). 
(Trimethylsilyl)(triiso-propylsilyl)acetylene (47) (349 mg, 1.36 mmol, 1.10 equiv) was then added 
dropwise, followed, after 15 min, by the addition of pyridine (110 μL, 1.36 mmol, 1.10 equiv). The 
mixture was stirred for 10 min. The solvent was then removed under reduced pressure and the 
yellow crude oil was dissolved in CH2Cl2 (50 mL). The organic layer was washed with 1 M HCl 
(50 mL) and the aqueous layer was extracted with CH2Cl2 (50 mL). The organic layers were 
combined, washed with a saturated solution of NaHCO3 (2 x 50 mL), dried over MgSO4, filtered 
and the solvent was evaporated under reduced pressure. Recrystallization from acetonitrile (ca 5 
mL) afforded 2e (414 mg, 0.854 mmol, 75%) as a white solid. Mp (Dec.); 165.0-170.2 °C; 1H NMR 
(400 MHz, CDCl3): δ 8.19 (d, J = 8.3 Hz, 1H, ArH), 7.65 (td, J = 8.2, 4.3 Hz, 1H, ArH), 7.45 (t, J 
= 8.7 Hz, 1H, ArH), 1.19-1.13 (m, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 165.0 (d, J = 269.3 
Hz), 162.7 (d, J = 4.5 Hz), 134.8 (d, J = 8.6 Hz), 122.1 (d, J = 4.0 Hz), 120.5 (d, J = 22.8 Hz), 
119.7 (d, J = 12.8 Hz), 118.5, 114.9, 66.2, 18.5, 11.1; IR ν 2951 (m), 2869 (m), 2247 (w), 2138 
(w), 1638 (s), 1569 (w), 1460 (m), 1322 (m), 1252 (m), 1069 (m), 1007 (w), 914 (m), 866 (m); 
HRMS (ESI) calcd. for C18H25FIO2Si+ [M+H]+ 447.0647; found 447.0647. 
 
2-Iodosyl-5-nitrobenzoic acid (57) and 2-iodosyl-3-nitrobenzoic acid (58) 
 
Following a reported procedure,19 fuming nitric acid (3.3 mL) was added to 2-iodobenzoic acid 
(56) (5.0 g, 20 mmol, 1.0 equiv) in concentrated H2SO4 (6.7 mL). The reaction was equipped with 
a cooler and a nitrous vapor trap and was heated at 100 °C for 1 h. The reaction mixture was then 
poured in ice-water and filtered. The resulting solid was refluxed in water (50 mL) and filtered. A 
second crop of precipitate was filtered from the mother liquors. Both solids were combined, washed 
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with acetone (10 mL) and dried under vacuum to afford 57 (2.19 g, 7.10 mmol, 36 %). The mother 
liquors were reduced to one third and then kept at 4 °C, the resulting precipitate was filtered, 
washed with acetone (10 mL) and dried under vacuum to afford 58 (630 mg, 2.04 mmol, 10 %). 
57: 1H NMR (400 MHz, (CD3)2SO): δ 8.73 (dd, J = 8.8, 2.6 Hz, 1H, ArH), 8.58 (d, J = 2.4 Hz, 1H, 
ArH), 8.54 (br s, 1H, OH), 8.11 (d, J = 8.8 Hz, 1H, ArH). 58: 1H NMR (400 MHz, (CD3)2SO): δ 
7.92 (dd, J = 7.9, 1.5 Hz, 1H, ArH), 7.79 (m, 1H, ArH), 7.67 (m, 1H, ArH). The characterization 




Following a reported procedure,19 trimethylsilyltriflate (646 μL, 3.56 mmol, 1.10 equiv, freshly 
distilled over CaH2) was added dropwise to a stirred solution of 2-iodosylbenzoic acid 57 (1.00 g, 
3.23 mmol, 1.00 equiv) in acetonitrile (15 mL) at 0 °C. After 15 min at room temperature, 
(trimethylsilyl)(triiso-propylsilyl)acetylene (47) (906 mg, 3.56 mmol, 1.10 equiv) was then added 
dropwise, followed, after 30 min, by the addition of pyridine (290 μL, 3.56 mmol, 1.10 equiv). The 
mixture was stirred for 20 min. The solvent was then removed under reduced pressure and the 
yellow crude oil was dissolved in CH2Cl2 (25 mL). The organic layer was washed with 1 M HCl 
(25 mL) and the aqueous layer was extracted with CH2Cl2 (25 mL). The organic layers were 
combined, washed with a saturated solution of NaHCO3 (20 mL), dried over MgSO4, filtered and 
the solvent was evaporated under reduced pressure. Recrystallization from acetonitrile (ca 20 mL) 
afforded 2f (960 mg, 2.02 mmol, 63%) as a white solid. Mp (Dec.); 198.0-206.0 °C; 1H NMR (400 
MHz, CDCl3): δ 9.20 (d, J = 2.6 Hz, 1H, ArH), 8.60 (ddd, J = 9.0, 2.5, 0.4 Hz, 1H, ArH), 8.53 (d, 
J = 8.9 Hz, 1H, ArH), 1.30-1.14 (m, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 166.4, 150.7, 
134.4, 129.0, 128.2, 126.5, 122.7, 115.2, 63.1, 18.5, 11.3. The characterization data corresponded 
to the reported values.19 
 




Following a reported procedure,19 NaIO4 (1.25 g, 5.84 mmol, 1.05 equiv) and 2-iodo-4,5-
dimethoxybenzoic acid (59) (1.71 g, 5.56 mmol, 1.00 equiv) were suspended in 30% (v:v) aq. 
AcOH (15 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was 
then diluted with cold water (40 mL) and allowed to cool to RT, protecting it from light. The crude 
product was collected by filtration, washed on the filter with ice water (3 x 4 mL) and acetone (3 x 
4 mL), and air-dried in the dark to give the pure product 60 (1.64 g, 5.06 mmol, 91%) as a colorless 
solid. 1H NMR (400 MHz, DMSO); δ 7.45 (s, 1H, ArH), 7.23 (s, 1H, ArH), 3.88 (d, 6H, J = 0.9 




Following a reported procedure,19 trimethylsilyltriflate (400 μL, 2.20 mmol, 1.1 equiv, freshly 
distilled) was added dropwise to a stirred solution of 60 (648 mg, 2.00 mmol, 1.0 equiv) in 
acetonitrile (10 mL). After 2 min, (trimethylsilyl)(triiso-propylsilyl)acetylene (47) (560 mg, 2.20 
mmol, 1.1 equiv) was added dropwise, followed, after 20 min, by the addition of pyridine (180 μL, 
2.20 mmol, 1.1 equiv). The mixture was stirred 20 min. The solvent was then removed under 
reduced pressure and the yellow crude oil was dissolved in dichloromethane (20 mL). The organic 
layer was washed with 1 M HCl (20 mL) and the aqueous layer was extracted with CH2Cl2 (20 
mL). The organic layers were combined, washed with a saturated solution of NaHCO3 (40 mL), 
dried over MgSO4, filtered and the solvent was evaporated under reduced pressure. 
Recrystallization from acetonitrile (ca 8 mL) and wash with hexanes afforded 2g (575 mg, 1.18 
mmol, 59%) as colorless cristals. Mp (Dec.) 180.0–183.0 °C; 1H NMR (400 MHz, CDCl3); δ 7.83 
(s, 1H, ArH), 7.61 (s, 1H, ArH), 3.99 (s, 3H, OMe), 3.97 (s, 3H, OMe), 1.14 (m, 21H, TIPS); 13C 
NMR (100 MHz, CDCl3); δ 166.7, 154.9, 152.2, 124.5, 113.8, 113.2, 107.8, 104.7, 66.0, 56.7, 56.5, 
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18.5, 11.2; IR 2945 (w), 1616 (m), 1569 (w), 1497 (m), 1464 (w), 1396 (m), 1317 (w), 1269 (m), 
1215 (m), 1181 (w), 1129 (w), 1026 (w), 921 (w), 884 (w), 778 (w), 734 (m), 708 (m), 639 (s). The 
characterization data corresponded to the reported values.19 
 
Triethyl trimethylsilylacetylene (61) 
 
Following a reported procedure,19 n-butyllithium (2.5 M in hexanes, 5.4 mL, 14 mmol, 1.0 equiv) 
was added dropwise to a stirred solution of ethynyltrimethylsilane (46) (1.36 g, 13.8 mmol, 1.00 
equiv) in THF (21 mL) at -78 °C. The mixture was then warmed to 0 °C and stirred for 5 min. The 
mixture was then cooled back to -78 °C and chlorotriethylsilane (2.3 mL, 14 mmol, 0.98 equiv) 
was added dropwise. The mixture was then allowed to warm to room temperature and stirred 
overnight. A saturated solution of ammonium chloride (20 mL) was added, and the reaction mixture 
was extracted with diethyl ether (2 x 20 mL). The organic layer was washed with water and brine, 
then dried over MgSO4, filtered and concentrated under reduced pressure to obtain a colorless 
liquid which was further purified by Kugelrohr distillation to yield 61 (3.4 g, 11 mmol, 83% yield) 
as a colorless liquid. 1H NMR (400 MHz, CDCl3): 0.99 (t, J = 7.9 Hz, 9H, SiCH2CH3), 0.59 (q, J 
= 7.9 Hz, 6H, SiCH2CH3), 0.17 (s, 9H, TMS); 13C NMR (100 MHz, CDCl3): 115.4, 111.2, 7.4, 4.4, 
0.0; IR ν 2958 (m), 2913 (m), 2879 (m), 1462 (w), 1414 (w), 1381 (w), 1250 (m), 1015 (m), 973 
(w), 908 (w), 844 (s), 773 (s), 731 (s), 702 (sh), 679 (sh). The characterization data corresponded 




Following a reported procedure,19 trimethylsilyltriflate (2.78 mL, 15.4 mmol, 1.1 equiv, freshly 
distilled over CaH2) was added dropwise to a stirred solution of 2-iodosylbenzoic acid (45) (3.71 
g, 14.0 mmol, 1.0 equiv) in acetonitrile (50 mL). After 15 min, 
(trimethylsilyl)(triethylsilyl)acetylene (61) (3.26 g, 15.4 mmol, 1.1 equiv) was then added 
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dropwise. After 30 min pyridine (1.25 mL, 15.4 mmol, 1.1 equiv) was added and the mixture was 
stirred for an additional 15 min. The solvent was then removed under reduced pressure and the 
yellow crude oil was dissolved in dichloromethane (50 mL). The organic layer was washed with 1 
M HCl (50 mL), and the aqueous layer was extracted with CH2Cl2 (50 mL). The organic layers 
were washed twice with saturated NaHCO3 (75 mL), dried over MgSO4, filtered and the solvent 
was evaporated under reduced pressure. The resulting solid was recristalized twice in CH3CN. The 
solid was washed with cold acetonitirile, hexanes and dried under high vacuum to afford 2h (2.95 
g, 7.64 mmol, 55% yield) as a slightly brown solid. Mp (Dec.) 155.0–158.0 °C. 1H NMR (400 
MHz, CDCl3): δ 8.40 (m, 1H, ArH), 8.24 (m, 1H, ArH), 7.75 (m, 2H, ArH), 1.06 (t, J = 8.0 Hz, 
9H, SiCH2CH3), 0.73 (q, J = 8.0 Hz; 6H, SiCH2CH3); 13C NMR (100 MHz, CDCl3): δ 166.5, 134.8, 
132.5, 131.6, 131.3, 126.1, 115.5, 115.1, 64.6, 7.4, 4.1; IR ν 3064 (w), 3062 (m), 2957 (m), 2911 
(m), 2877 (m), 1621 (s), 1587 (m), 1561 (m), 1460 (m), 1440 (m), 1415 (w), 1378 (w), 1336 (m), 
1297 (m), 1237 (w), 1149 (w), 1113 (w), 1010 (m), 976 (w), 912 (w), 912 (w), 834 (m), 804 (w), 




Following a reported procedure,21 2-iodobenzoic acid (44) (3.76 g, 15.2 mmol, 1.00 equiv), para-
toluenesulfonic acid monohydrate (TsOH.H2O, 2.88 g, 15.2 mmol, 1.00 equiv) and meta-
chloroperoxybenzoic acid (mCPBA-70%, 4.11 g, 16.7 mmol, 1.10 equiv) were dissolved in CH2Cl2 
(30 mL) and 2,2,2-trifluoroethanol (30 mL). The mixture was stirred at room temperature under 
nitrogen for 1 h, after which 5-chloro-1-pentynyl-1-boronic acid pinacol ester (4.85 g, 21.2 mmol, 
1.40 equiv) was added in one portion. The reaction mixture was stirred for 90 minutes at room 
temperature, filtered and concentrated in vacuo. The resulting oil was dissolved in CH2Cl2 (15 mL) 
and under vigorous stirring, saturated solution of NaHCO3 (15 mL) was added. The mixture was 
stirred for 10 minutes, the two layers were separated and the aqueous layer was extracted with 
additional portions of CH2Cl2 (3 x 15 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. The crude product was purified by flash column 
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chromatography using ethyl acetate to afford 2i (3.76 g, 10.8 mmol, 71%) as a white solid. TLC 
(EtOAc): Rf = 0.15, KMnO4; Mp: 138.5-141.7 °C; 1H NMR (CDCl3, 400 MHz): δ 8.41-8.34 (m, 
1H, ArH), 8.22-8.13 (m, 1H, ArH), 7.82-7.68 (m, 2H, ArH), 3.71 (t, J = 6.1 Hz, 2H, ClCH2CH2), 
2.82 (t, J = 6.9 Hz, 2H, CCCH2CH2), 2.18-2.05 (m, 2H, ClCH2CH2); 13C NMR (CDCl3, 100 MHz): 
δ 166.8, 134.9, 132.5, 131.6, 131.6, 126.4, 115.8, 107.1, 43.4, 41.2, 30.7, 18.0; IR ν 2942 (w), 2866 
(w), 2171 (w), 2091 (w), 1727 (w), 1617 (s), 1556 (w), 1441 (w), 1339 (m), 1213 (w), 1023 (w), 




Following a reported procedure,21 to a mixture of trimethylsilylacetylene (8.33 g, 85.0 mmol, 1.20 
equiv) and dry THF (46 mL) was added at -78 °C under nitrogen 2.5 M nBuLi in hexanes (33.9 
mL, 85.0 mmol, 1.20 equiv) over a 10 minute time period. The resulting light yellow solution was 
stirred at -78 °C for 1 h, after which a mixture consisting of 1-bromotetradecane (62) (19.6 g, 70.7 
mmol, 1.00 equiv), hexamethylphosphoramide (HMPA, 14.2 mL, 78.0 mmol, 1.10 equiv) and dry 
THF (23 mL) was slowly added via cannula over a 20 minutes time period. The reaction mixture 
was stirred for 1 h at -78 °C, followed by 24 h of stirring at room temperature. The reaction was 
quenched at 0 °C with saturated aq. NH4Cl (50 mL) and diluted with water (10 mL) and EtOAc 
(50 mL). The two layers were separated and the aq. layer was extracted with additional portions of 
EtOAc (3 x 50 mL). The combined organic layers were washed with water (2 x 100 mL), brine 
(100 mL), dried over MgSO4, filtered and concentrated in vacuo. The light brown crude liquid was 
finally pushed through a small plug of silica gel with pentane as eluent to afford pure hexadec-1-
yn-1-yltrimethylsilane (63) (19.3 g, 65.5 mmol, 92.7% yield) as a colorless liquid. TLC (pentane): 
Rf = 0.78, KMnO4; 1H NMR (CDCl3, 400 MHz): δ 2.19 (t, J = 7.1 Hz, 2H, CCCH2), 1.54-1.44 (m, 
2H, CH2), 1.42-1.18 (m, 22H, CH2), 0.87 (t, J = 6.7 Hz, 3H, CH2CH3), 0.13 (s, 9H, TMS); 13C 
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NMR (CDCl3, 100 MHz): δ 107.7, 84.3, 32.2, 29.9, 29.8, 29.7, 29.6, 29.3, 29.0, 28.9, 22.9, 20.0, 
14.3, 0.3; IR ν 2924 (m), 2854 (m), 2175 (w), 1461 (w), 1249 (w), 910 (w), 841 (s), 761 (w), 736 
(m). The characterization data corresponded to the reported values.21 
Following a reported procedure,21 2-iodobenzoic acid (44) (8.00 g, 32.2 mmol, 1.00 equiv), para-
toluenesulfonic acid monohydrate (TsOH.H2O, 6.13 g, 32.2 mmol, 1.00 equiv) and meta-
chloroperoxybenzoic acid (mCPBA-70%, 8.74 g, 35.5 mmol, 1.10 equiv) were dissolved in CH2Cl2 
(60 mL) and 2,2,2-trifluoroethanol (60 mL). The mixture was stirred at room temperature under 
nitrogen for 1 h, after which hexadec-1-yn-1-yltrimethylsilane (63) (13.3 g, 45.1 mmol, 1.40 equiv) 
was added in one portion. The reaction mixture was stirred for 14 h at room temperature, filtered 
and concentrated in vacuo. The resulting oil was dissolved in CH2Cl2 (400 mL) and under vigorous 
stirring, saturated solution of NaHCO3 (400 mL) was added. The mixture was stirred for 1 h, the 
two layers were separated and the aqueous layer was extracted with additional portions of CH2Cl2 
(3 x 100 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The crude product was purified by flash column chromatography using EtOAc to afford 2j 
(6.02 g, 12.9 mmol, 40%) as a white solid. TLC (EtOAc): Rf = 0.36, KMnO4; Mp: 102.6-105.3 °C; 
1H NMR (CDCl3, 400 MHz): δ 8.44-8.37 (m, 1H, ArH), 8.21-8.14 (m, 1H, ArH), 7.80-7.70 (m, 
2H, ArH), 2.59 (t, J = 7.1 Hz, 2H, CCCH2), 1.65 (p, J = 7.1 Hz, 2H, CCCH2CH2), 1.52-1.40 (m, 
2H), 1.39-1.19 (m, 20H, CH2), 0.86 (t, J = 6.7 Hz, 3H, CH2CH3); 13C NMR (CDCl3, 100 MHz): δ 
166.6, 134.7, 132.5, 131.7, 131.6, 126.2, 115.7, 109.9, 39.5, 32.1, 29.8, 29.7, 29.6, 29.5, 29.2, 29.1, 
28.3, 22.8, 20.6, 14.3; IR ν 2924 (s), 2853 (m), 2166 (w), 1649 (m), 1623 (m), 1439 (w), 908 (m), 






Following a reported procedure,15 to a solution of 1,7-octadiyne 64 (10.6 g, 100 mmol, 1.00 equiv) 
in dry THF (150 mL) was added at -78 °C under nitrogen 1 M lithium bis(trimethylsilyl)amide in 
THF (LiHMDS, 100 mL, 100 mmol, 1.00 equiv). The solution was stirred at -78 °C for 30 minutes, 
after which trimethylsilyl chloride (TMSCl, 13.0 mL, 100 mmol, 1.00 equiv) was added dropwise. 
The reaction was warmed to room temperature and stirred for 2 h. The reaction was cooled to 0 °C 
and quenched by adding water (10 mL). The mixture was diluted with 1 M HCl (200 mL) and 
extracted with diethyl ether (100 mL and 2 x 75 mL). The combined organic layers were washed 
with brine (200 mL), dried over MgSO4, filtered and concentrated in vacuo. The crude product was 
purified by vacuum distillation using a 20 cm Vigreux column (oil bath set to 98 °C at 0.3 mbar) 
furnishing pure trimethyl(octa-1,7-diyn-1-yl)silane (65) (8.37 g, 46.9 mmol, 47%) as a colorless 
liquid. TLC (pentane): Rf = 0.2, KMnO4; 1H NMR (CDCl3, 400 MHz): δ 2.28-2.17 (m, 4H), 1.93 
(t, J = 2.7 Hz, 1H, CCH), 1.68-1.57 (m, 4H), 0.13 (s, 9H, TMS); 13C NMR (CDCl3, 100 MHz): δ 
107.0, 84.9, 84.2, 68.6, 27.7, 27.6, 19.5, 18.1, 0.3; IR ν 3309 (w), 2951 (w), 2175 (w), 1250 (m), 
912 (w), 841 (s), 761 (m), 734 (m). The characterization data corresponded to the reported values.15  
 
Following a reported procedure,15 2-iodobenzoic acid (44) (8.43 g, 33.3 mmol, 1.00 equiv), para-
toluenesulfonic acid monohydrate (TsOH.H2O, 6.40 g, 33.3 mmol, 1.00 equiv) and meta-
chloroperoxybenzoic acid (mCPBA-70%, 9.04 g, 36.7 mmol, 1.10 equiv) were dissolved in CH2Cl2 
(60 mL) and 2,2,2-trifluoroethanol (60 mL). The mixture was stirred at room temperature under 
nitrogen for 1 h, after which trimethyl(octa-1,7-diyn-1-yl)silane (65) (8.32 g, 46.7 mmol, 1.40 
equiv) was added. The reaction mixture was stirred for 15 h at room temperature and then filtered 
and concentrated in vacuo. The resulting light being solid was dissolved in CH2Cl2 (500 mL) and 
under vigorous stirring, saturated solution of NaHCO3 (500 mL) was added. The mixture was 
stirred for 1 h, the two layers were separated and the aqueous layer was extracted with additional 
portions of CH2Cl2 (3 x 150 mL). The combined organic layers were dried over MgSO4, filtered 
and concentrated in vacuo. The crude product was purified by flash column chromatography using 
ethyl acetate to afford 2k (4.2 g, 9.9 mmol, 30%) as a white solid. Mp: 152.3–155.6 °C; TLC 
(EtOAc:MeOH, 9:1 v/v): Rf = 0.59, KMnO4; 1H NMR (CDCl3, 400 MHz): δ 8.37 (dd, J = 6.7, 2.3 
Hz, 1H, ArH), 8.17 (dd, J = 7.8, 1.5 Hz, 1H, ArH), 7.82-7.66 (m, 2H, ArH), 2.63 (t, J = 6.8 Hz, 
2H,), 2.29 (t, J = 6.7 Hz, 2H), 1.83-1.62 (m, 4H), 0.13 (s, 9H, TMS); 13C NMR (CDCl3, 100 MHz): 
δ 166.7, 134.8, 132.4, 131.7, 131.5, 126.3, 115.7, 109.1, 106.4, 85.4, 40.0, 27.7, 27.3, 20.2, 19.4, 
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0.3; IR ν 2955 (w), 2170 (w), 1647 (m), 1621 (s), 1439 (w), 1329 (m), 1296 (w), 1249 (m), 840 (s), 




Following a reported procedure,15 2-iodobenzoic acid (44) (6.41 g, 25.8 mmol, 1.00 equiv), para-
toluenesulfonic acid monohydrate (TsOH.H2O, 4.91 g, 25.8 mmol, 1.00 equiv) and meta-
chloroperoxybenzoic acid (mCPBA-70%, 7.00 g, 28.4 mmol, 1.10 equiv) were dissolved in 
dichloromethane (48 mL) and 2,2,2-trifluoroethanol (48 mL). The mixture was stirred at room 
temperature under nitrogen for 1 h, after which (cyclopropylethynyl)trimethylsilane (5.00 g, 36.2 
mmol, 1.40 equiv) was added in one portion. The reaction mixture was stirred for 12 h at room 
temperature, filtered and concentrated in vacuo. The resulting oil was dissolved in CH2Cl2 (400 
mL) and under vigorous stirring, a saturated solution of NaHCO3 (400 mL) was added. The mixture 
was stirred for 1 h, the two layers were separated and the aqueous layer was extracted with 
additional portions of CH2Cl2 (3 x 100 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. The crude product was purified by flash column 
chromatography using ethyl acetate to afford 2l (2.11 g, 6.76 mmol, 26 %) as a white solid. Mp 
(Dec.): 174.2–177.6 °C; TLC (EtOAc:MeOH, 9:1 v/v): Rf = 0.46, KMnO4; 1H NMR (CDCl3, 400 
MHz): δ 8.34 (dd, J = 7.0, 2.1 Hz, 1H, ArH), 8.18-8.09 (m, 1H, ArH), 7.81-7.63 (m, 2H, ArH), 
1.59 (tt, J = 8.2, 5.0 Hz, 1H, CH), 1.07-0.85 (m, 4H, CH2CH2); 13C NMR (CDCl3, 100 MHz): δ 
166.7, 134.7, 132.3, 131.7, 131.4, 126.2, 115.9, 113.3, 35.0, 9.8, 1.1; IR ν 3464 (w), 3077 (w), 
3012 (w), 2238 (w), 2159 (m), 1607 (s), 1559 (m), 1438 (m), 1338 (m), 1298 (m), 833 (m), 744 






Following a reported procedure,19 trimethylsilyl triflate (7.50 mL, 41.5 mmol, 1.10 equiv) was 
added to a suspension of 2-iodosylbenzoic acid (45) (10.0 g, 37.7 mmol, 1.00 equiv) in CH2Cl2 
(100 mL) at room temperature. The resulting yellow mixture was stirred for 1 h, followed by the 
dropwise addition of trimethyl(phenylethynyl)silane (66) (8.10 mL, 41.5 mmol, 1.10 equiv) 
(slightly exothermic). The resulting suspension was stirred for 6 h at room temperature, during this 
time a white solid was formed. A saturated solution of NaHCO3 (100 mL) was then added and the 
mixture was stirred vigorously. The resulting suspension was filtered on a glass filter of porosity 
4. The two layers of the mother liquors were separated and the organic layer was washed with 
saturated solution of NaHCO3 (100 mL), dried over MgSO4, filtered and evaporated under reduced 
pressure. The resulting mixture was combined with the solid obtained by filtration and boiled in 
CH3CN (ca 300 mL). The mixture was cooled down, filtered and dried under high vacuum to afford 
2m (6.08 g, 17.4 mmol, 46 %) as a white solid. Mp (Dec.); 155.0–160.0 °C (lit 153-155°C); 1H 
NMR (400 MHz, CDCl3); δ 8.46 (m, 1H, ArH), 8.28 (m, 1H, ArH), 7.80 (m, 2H, ArH), 7.63 (m, 
2H, ArH), 7.48 (m, 3H, ArH); 13C NMR (100 MHz, CDCl3): δ 163.9, 134.9, 132.9, 132.5, 131.6, 
131.3. 130.8, 128.8, 126.2, 120.5, 116.2, 106.6, 50.2. The characterization data corresponded to 




Following a reported procedure,19 iodo-mestylene (67) (1.05 g, 4.27 mmol, 1 equiv) was dissolved 
in Et3N (10 mL) (without prior drying). After three freeze-thraw-pump cycle, PdCl2(PPh3)2 (30 
mg, 0.42 mmol, 0.1 equiv) and CuI (16 mg, 0.84 mmol, 0.2 equiv) were added under N2. After the 
addition of trimethylsilylacetylene (46) (1.2 mL, 8.5 mmol, 2 equiv), the green suspension was 
stirred at RT for 1 h. The reaction mixture was reduced under vacuum, dissolved in CH2Cl2 (30 
mL), washed with 5% EDTA solution (30 mL) and water (30 mL). The organic layers were them 
dried over MgSO4, filtered and reduced under vacuum. The resulting oil was purified by column 
chromatography (PET) to afford 68 (526 mg, 2.43 mmol, 66%) along with 15% of starting material. 
TLC (pentane): Rf = 0.5, KMnO4; 1H NMR (400 MHz, CDCl3): δ 6.87 (s, 2H, ArH), 2.41 (s, 6H, 






Following a reported procedure,19 trimethylsilyl triflate (212 μL, 1.15 mmol, 1.1 equiv) was added 
to a suspension of 2-iodosylbenzoic acid (45) (1.00 g, 1.05 mmol, 1 equiv) in CH2Cl2 (4 mL) at 
RT. The resulting yellow mixture was stirred for 1 h, followed by the dropwise addition of 
(mesitylethynyl)trimethylsilane (68) (250 mg, 1.15 mmol, 1.1 equiv) dissolved in CH2Cl2 (1 mL). 
The resulting suspension was stirred for 6 h at RT. A saturated solution of NaHCO3 (5 mL) was 
then added and the mixture was stirred vigorously. The layers were separated and the organic layer 
was washed with sat. NaHCO3 (10 mL), dried over MgSO4, filtered and evaporated under reduced 
pressure. The resulting solid was recrystallized in CH3CN (ca 20 mL). The mother liquors were 
concentrated and and the obtained solid recrystallized in CH3CN (4 mL). Both solids were 
combined, washed with pentane and dried under high vacuum to afford 2n (120 mg, 0.307 mmol, 
30%) as a tan solid. Mp (Dec.) 171.0–175.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.38 (m, 1H, ArH), 
8.28 (m, 1H, ArH), 7.72 (m, 2H, ArH), 6.92 (s, 2H, MesH), 2.45 (s, 6H, 2 X CH3), 2.31 (s, 3H, 
CH3); 13C NMR (100 MHz, CDCl3): δ 166.7, 142.1, 140.5, 134.5, 132.2, 131.5, 131.3, 128.0, 126.2, 
117.5, 116.5, 105.1, 55.6, 21.4, 21.0; IR 2979 (w), 2916 (w), 2247 (w), 2131 (w), 1650 (m), 1623 
(m), 1562 (w), 1439 (w), 1333 (w), 1292 (w), 1212 (w), 1146 (w), 1008 (w), 906 (s), 855 (w), 833 




Following a reported procedure,22 trimethylsilyl triflate (1.0 mL, 5.5 mmol, 1.1 equiv) was added 
to a suspension of 2-iodosylbenzoic acid (45) (1.32 g, 5.00 mmol, 1.00 equiv) in CH2Cl2 (15 mL) 
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at room temperature. The resulting suspension was stirred for 3 h, followed by the drop wise 
addition of ((2-bromophenyl)ethynyl)trimethylsilane (69) (1.17 g, 5.50 mmol, 1.10 equiv). The 
resulting suspension was stirred for 6 h at room temperature. A saturated solution of NaHCO3 (20 
mL) was then added and the mixture was stirred vigorously for 30 minutes, the two layers were 
separated and the organic layer was washed with saturated solution of NaHCO3 (20 mL), dried 
over MgSO4, filtered and evaporated under reduced pressure. The resulting solid was boiled in 
CH3CN (ca 20 mL). The mixture was cooled down, filtered and dried under high vacuum to afford 
2o (1.50 g, 3.51 mmol, 70%) as a white solid. Mp (Dec.): 174.0-177.0 °C; 1H NMR (400 MHz, 
CDCl3): δ 8.44 (td, J = 7.3, 2.1 Hz, 2H, ArH), 7.84–7.74 (m, 2H, ArH), 7.68 (d, J = 1.1 Hz, 1H, 
ArH), 7.61 (dd, J = 7.6, 1.7 Hz, 1H, ArH), 7.36 (dtd, J = 22.4, 7.5, 1.5 Hz, 2H, ArH); 13C NMR 
(100 MHz, CDCl3): δ 166.6, 135.2, 134.7, 133.0, 132.7 , 131.8, 131.3, 127.6, 126.8, 126.4, 123.2, 
116.5, 104.3, 55.4; IR ν 2358 (w), 2155 (w), 1638 (s), 1616 (m), 1585 (w), 1466 (w), 1316 (m), 




Following a reported procedure,22 trimethylsilyl triflate (1.0 mL, 5.5 mmol, 1.1 equiv) was added 
to a suspension of 2-iodosylbenzoic acid (45) (1.32 g, 5.00 mmol, 1 equiv) in CH2Cl2 (15 mL) at 
RT. The resulting suspension was stirred for 3 h, followed by the drop wise addition of ((4-
bromophenyl)ethynyl)trimethylsilane (70) (1.17 g, 5.50 mmol, 1.1 equiv), which was dissolved in 
CH2Cl2 (1 mL). The resulting suspension was stirred for 6 h at RT. A saturated solution of NaHCO3 
(20 mL) was then added and the mixture was stirred vigorously for 30 minutes, the two layers were 
separated and the organic layer was washed with sat. NaHCO3 (20 mL), dried over MgSO4, filtered 
and evaporated under reduced pressure. The resulting solid was boiled in CH3CN (20 mL). The 
mixture was cooled down, filtered and dried under high vacuum to afford 2p (1.00 g, 2.34 mmol, 
47%) as a pale yellow solid. Mp (Dec.):158.0-163.0 °C; 1H NMR (400 MHz, CDCl3): δ 8.51–8.30 
(m, 1 H, ArH), 8.30–8.13 (m, 1 H, ArH), 7.84–7.72 (m, 2 H, ArH), 7.58 (d, 2 H, J = 8.5 Hz, ArH), 
7.46 (d, 2 H, J = 8.5 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ 166.6, 135.1, 134.3, 132.7, 132.3, 
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131.9, 131.4, 126.3, 125.7, 119.6, 116.3, 105.4, 52.1; IR ν 2155 (w), 1612 (s), 1559 (w), 1479 (w), 





4. Synthesis of ligands 
Ligands 4a, 4g-i and 4k-n were purchased from Aldrich and TCI, and used as such unless stated 
otherwise. Ligand 4f was synthesized using a reported procedure.23 
Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)methane (4p) 
 
Following a reported procedure,24 to a solution of (S)-tert-leucinol (71) (0.94 g, 8.0 mmol, 2.0 
equiv) in CH2Cl2 (40 mL) was added imidate 72 (0.93 g, 4.0 mmol, 1.0 equiv). The resulting cloudy 
solution was stirred at room temperature for 36 h. The reaction mixture was diluted with water (8 
mL) and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were washed with brine 
(40 mL), dried over MgSO4, and concentrated. The resulting oily residue was distilled bulb-to-bulb 
(Kugelrohr distillation, 150 °C at 0.2 mbar) to afford bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-
yl)methane (4p) (0.600 g, 2.84 mmol, 71%) as a white solid: TLC (EtOAc:pentane, 1:1 v/v): Rf = 
0.16, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.13 (dd, J = 10.1, 8.7 Hz, 2H, 2 X OCHa), 4.02 (dd, 
J = 8.7, 7.7 Hz, 2H, 2 X C(CH3)3CH), 3.81 (ddt, J = 10.1, 7.8, 1.1 Hz, 2H, 2 X OCHb), 3.27 (t, J = 
1.2 Hz, 2H, O(C=N)CH2), 0.82 (s, 18H, 2 X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 161.5, 76.0, 




Following a reported procedure,24 to a solution of bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-
yl)methane (4p) (75 mg, 0.28 mmol, 1.0 equiv) in THF (5 mL) in a 20 mL microwave vial, was 
added TMEDA (85 μL, 0.56 mmol, 2.0 equiv) and i-Pr2NH (40 mL, 0.28 mmol, 1.0 equiv). The 
solution was cooled to -78 °C and n-BuLi (0.38 mL, 1.5 M in hexane, 0.56 mmol, 2.0 equiv) was 
added. The reaction mixture was warmed to -20 °C and stirred at that temperature for 30 minutes. 
The solution was cooled back to -78 °C and 1,2 dibromoethane (73) (25 μL, 0.28 mmol, 2.0 equiv) 
was added in 10 minutes. After the addition, the cold bath was removed and the reaction mixture 
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was allowed to stir at room temperature for an additional 16 h. The reaction mixture was quenched 
by the addition of sat. aq. NH4Cl (2.5 mL) and diluted with water (2 mL) to dissolve the resulting 
salts. The mixture was extracted with diethylether (3 X 10 mL). The combined organic layers were 
washed with brine (10 mL), dried over MgSO4, and concentrated. The resulting oily residue was 
purified by column chromatography using 1:2 to 1:1 EtOAc:pentane as mobile phase to afford 
(4S,4'S)-2,2'-(cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) (4b) as a white solid. 
TLC (EtOAc:pentane, 1:2 v/v): Rf = 0.15, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.18 (dd, J = 
10.0, 8.6 Hz, 2H, 2 X OCHa), 4.10 (dd, J = 8.7, 7.3 Hz, 2H, 2 X C(CH3)3CH), 3.82 (dd, J = 10.0, 
7.2 Hz, 2H, 2 X OCHb), 1.52–1.47 (m, 2H, 2 X CHa of CyP), 1.30–1.24 (m, 2H, 2 X CHb of CyP), 
0.86 (s, 18H, 2 X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 165.4, 75.2, 69.1, 33.8, 25.7, 18.2, 




Following a reported procedure,24 to a solution of bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-
yl)methane (4p) (75 mg, 0.28 mmol, 1.0 equiv) in THF (5 mL) in a 20 mL microwave vial was 
added TMEDA (85 μL, 0.56 mmol, 2.0 equiv) and i-Pr2NH (40 mL, 0.28 mmol, 1.0 equiv). The 
solution was cooled to -78 °C and n-BuLi (0.38 mL, 1.5 M in hexane, 0.56 mmol, 2.0 equiv) was 
added. The reaction mixture was warmed to -20 °C and stirred at that temperature for 30 minutes. 
The solution was cooled back to -78 °C and 1,4 diiodobutane (37 μL, 0.28 mmol, 2.0 equiv) was 
added in 10 minutes. After the addition. the cold bath was removed and the reaction mixture was 
allowed to stir at room temperature for an additional 16 h. The reaction mixture was quenched by 
the addition of sat. aq. NH4Cl (2.5 mL) and diluted with water (2 mL) to dissolve the resulting 
salts. The mixture was extracted with diethylether (3 X 10 mL). The combined organic layers were 
washed with brine (10 mL), dried over MgSO4, and concentrated. The resulting oily residue was 
purified by column chromatography using 1:4 EtOAc:pentane as mobile phase to afford (4S,4'S)-
2,2'-(cyclopentane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) (4c) as a white solid. TLC 
(EtOAc:pentane, 1:2 v/v): Rf = 0.6, KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.15 (dd, J = 10.1, 8.6 
Hz, 2H, 2 X OCHa), 4.07 (dd, J = 8.7, 7.1 Hz, 2H, 2 X C(CH3)3CH), 3.84 (dd, J = 10.0, 7.1 Hz, 
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2H, 2 X OCHb), 2.43-2.33 (m, 2H, 2 X CCHaCH2), 2.20–2.05 (m, 2H, 2 X CCHbCH2), 1.81–1.62 
(m, 4H, 2 X CCH2CH2), 0.86 (s, 18H, 2 X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 168.0, 75.3, 




Following a reported procedure,25 a Schlenk tube was charged with dry THF (2 mL), TMEDA (46 
µL, 0.30 mmol, 2.0 equiv) and i-Pr2NH (43 µL, 0.30 mmol, 2.0 equiv). The solution was cooled to 
-20 °C and n-BuLi (0.20 mL, 1.5 M in hexane, 0.30 mmol, 2.0 equiv) was added. The reaction 
mixture was stirred for 1 h at that temperature and 75 (50 mg, 0.15 mmol, 1.0 equiv) in THF (2mL) 
was added. The mixture was stirred for 3 h. Then, MeI (38 µL, 0.6 mmol, 4.0 equiv) was added at 
-20 °C. After the addition, the cold bath was removed and the reaction mixture was heated to 60 
°C for an additional 24 h. The solution was cooled, washed with sat. NH4Cl (20 mL) and extracted 
with EtOAc (3 x 30 mL). The combined organic layers were dried over MgSO4, and removed under 
reduced pressure, to afford (3aR,3a'R,8aS,8a'S)-2,2'-(propane-2,2-diyl)bis(8,8a-dihydro-3aH-
indeno[1,2-d]oxazole) (4d) (53.5 mg, 0.15 mmol, quant.) as a white solid. No purification was 
needed. TLC (EtOAc:MeOH, 9:1 v/v): Rf = 0.53, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.54–
7.45 (m, 2H, ArH), 7.30–7.18 (m, 6H, ArH), 5.52 (d, J = 7.9 Hz, 2H, 2 X N-CH), 5.28-5.25 (m, 
2H, 2 X O-CH), 3.30 (dd, J = 17.9, 7.1 Hz, 2H, 2 X ArCHa), 2.95 (dd, J = 17.9, 1.9 Hz, 2H, 2 X 
ArCHb), 1.42 (s, 6H, 2 X CH3); 13C NMR (100 MHz, CDCl3): δ 169.1, 141.8, 139.7, 128.3, 127.3, 







Following a reported procedure,26 to a solution of dihydrobisoxazoline 75 (330 mg, 1.00 mmol, 
1.00 equiv) in THF (4 mL), was added NaH (120 mg, 60% dispersion in paraffin liquid, 3.00 mmol, 
3.00 equiv) in portions at 0 °C. After complete addition, the mixture was stirred for 30 min. at that 
temperature. A solution of dibromoethane (73) (130 μL, 1.50 mmol, 1.50 equiv) in THF (1 mL) 
was then added dropwise at 0 °C over 10 minutes. After the addition, the ice bath was removed and 
the reaction mixture was heated to 50 °C for an additional 2 h. The reaction was quenched with sat. 
NH4Cl (10 mL) and extracted with CH2Cl2 (3 X 20 mL). The combined organic layers were dried 
over MgSO4, and removed under reduced pressure. The crude product was purified by 
chromatography on silica gel using 2% MeOH/EtOAc followed by recrystallization 
(EtOAc/hexane, 1:4, 15 mL) to afford (3aR,3a'R,8aS,8a'S)-2,2'-(cyclopropane-1,1-diyl)bis(8,8a-
dihydro-3aH-indeno[1,2-d]oxazole) (4e) (220 mg, 0.617 mmol, 62%) as a white solid. TLC 
(EtOAc:MeOH, 9:1 v/v): Rf = 0.50, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.48–7.41 (m, 2H, 
ArH), 7.25–7.17 (m, 6H, ArH), 5.52 (d, J = 7.9 Hz, 2H, 2 x N-CH), 5.41–5.23 (m, 2H, 2 X O-CH), 
3.38 (dd, J = 17.9, 7.0 Hz, 2H, 2 X ArCHa), 3.19 (dd, J = 17.9, 1.9 Hz, 2H, 2 X ArCHb), 1.44–1.15 
(m, 4H, CH2CH2); 13C NMR (100 MHz, CDCl3): δ 166.0, 141.9, 139.8, 128.5, 127.5, 125.7, 125.3, 




Following a reported procedure,28 diethyl methylmalonate (76) (0.850 mL, 5.00 mmol, 1.00 equiv) 
and (S)-tert-leucinol (71) (1.23 g, 10.5 mmol, 2.10 equiv) were added to a Schlenk tube. The 
mixture was stirred for 3 days at 120 °C. The reaction mixture was cooled down to room 
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temperature to obtain the product, which was used in the following step without further 
purification. 
Following a reported procedure,29 a 50 mL Schlenk flask was charged with bis((S)-1-hydroxy-3,3-
dimethylbutan-2-yl)-2-methylmalonamide (1.44 g, 4.54 mmol, 1.00 equiv), 4-(dimethylamino)-
pyridine (0.06 g, 0.05 mmol, 0.100 equiv), and CH2Cl2 (40 mL). Triethylamine (3.00 mL, 21.5 
mmol, 4.75 equiv) was then added. A solution of p-toluenesulfonyl chloride (1.88 g, 9.90 mmol, 
2.10 equiv) in CH2Cl2 (10 mL) was added slowly. The resulting bright yellow solution was stirred 
at room temperature for 24 h. It was diluted with CH2Cl2 (10 mL) and washed with sat. NH4Cl (15 
mL). The aq. layer was back-extracted with CH2Cl2 (3 X 15 mL). The combined organic extracts 
were washed with sat.NaHCO3 (30 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated under vacuum. The crude product was purified by column chromatography using 98:2 
CH2Cl2:MeOH to afford (4S,4'S)-2,2'-(ethane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) (4o) 
(1.00 g, 3.57 mmol, 79%) as a colorless thick liquid. TLC (EtOAc:MeOH, 9:1 v/v): Rf = 0.53, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 4.21–4.13 (m, 2H, 2 X OCHa), 4.12–4.01 (m, 2H, 2 X 
C(CH3)3CH), 3.97–3.76 (m, 2H, 2 X OCHb), 3.61–3.45 (m, 1H, CH3CH), 1.46 (d, J = 7.3 Hz, 3H, 
CH3CH), 0.88 (s, 9H, C(CH3)3), 0.87 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 165.5, 
165.3, 75.4, 68.9, 34.0, 33.8, 25.7, 25.6, 15.3. The characterization data corresponded to the 
reported values.29  
Following a reported procedure,30 to a solution of bisoxazoline 4o (70 mg, 0.25 mmol, 1.0 equiv) 
in dry THF (5 mL) was added dropwise t-BuLi (0.23 mL, 1.6 M in heptane, 0.36 mmol, 1.44 equiv) 
over 15~20 minutes. at -78 ℃ under nitrogen. The resulting yellow solution was stirred for an 
additional 1 h at this temperature. Then a solution of 2-chloromethyl oxazoline (77) (66 mg, 0.38 
mmol, 1.5 equiv) in THF (2.5 mL) was added dropwise at -78 ℃ over 10 minutes. The solution 
was slowly warmed to room temperature and was stirred for further 10 h. The mixture was diluted 
with CH2Cl2 (5 mL) and was washed with H2O (5 mL). The aqueous layer was extracted with 
CH2Cl2 (5 mL) and the combined organic layers were dried over MgSO4, filtered and concentrated. 
The residue was purified by flash chromatography using 10:1 pentane/acetone to afford 
(4S,4'S,4''S)-2,2',2''-(propane-1,2,2-triyl)tris(4-(tert-butyl)-4,5-dihydrooxazole) (4j) (48.0 mg, 
0.114 mmol, 46%) as a white solid. TLC (acetone:pentane, 1:10 v/v): Rf = 0.37, KMnO4; 1H NMR 
(400 MHz, CDCl3): δ 4.19–3.77 (m, 9H, 3 X OCH2 and 3 X C(CH3)3CH), 3.14 (d, J = 15.1 Hz, 
1H, CHaCCH3), 2.91 (d, J = 15.1 Hz, 1H, CHbCCH3), 1.60 (s, 3H, CH2CCH3), 0.89–0.77 (m, 27H, 
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3 X C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 167.0, 166.7, 163.7, 75.7, 75.6, 75.4, 69.1, 69.0, 
68.3, 40.8, 34.8, 33.9, 33.8, 33.4, 25.9, 25.8, 25.7, 21.2. The characterization data corresponded to 





5. Optimization of the reaction conditions 
a) Screening of ligands 
A flame dried 5 mL microwave vial was charged under nitrogen with catalyst (3.00 µmol, 0.02 
equiv), ligand (3.75 µmol, 0.025 equiv) and dry DCE (1 mL). The resulting solution was stirred at 
room temperature for 30 minutes. To this solution was added a mixture of 1-[(triiso-
propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) (0.15 mmol, 1.0 equiv) and ethyl 2-
diazoacetate (1a) (0.30 mmol, 2.0 equiv) in dry DCE (2 mL) in 2 min and the resulting reaction 
mixture was stirred until the reaction was completed (monitored by TLC, EtOAc:pentane, 1:40 
v/v), the solvent was evaporated under reduced pressure and the crude product was purified by 





b) Screening of solvents 
A flame dried 5 mL microwave vial was charged under nitrogen with Cu(OTf)2(3.00 µmol, 0.02 
equiv), ligand 4e (3.75 µmol, 0.025 equiv) and solvent (1 mL). The resulting solution was stirred 
at room temperature for 30 minutes. To this solution was added a mixture of 1-[(triiso-
propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) (0.15 mmol, 1.0 equiv) and ethyl 2-
diazoacetate (1a) (0.30 mmol, 2.0 equiv) in solvent (2 mL) in 2 min and the resulting reaction 
mixture was stirred until the reaction was completed (monitored by TLC, EtOAc:pentane, 1:40 
v/v), the solvent was evaporated under reduced pressure and the crude product was purified by 
column chromatography (EtOAc:pentane, 1:40 v/v) directly without any further work-up. 
 
Entry solvent Time  Yield (%) ee 
1 xylenes 2 h 79 69 
2 PhCl 2 h 84 70 
3 toluene 2 h 80 59 
4 PhCl/PhCH3 2 h 68 55 
5 PhCl/p-xylene 2 h 78 65 
6 o-dichlorobenzene 3 h 78 71 
 
c) Screening of copper catalysts 
A flame dried 5 mL microwave vial was charged under nitrogen with catalyst (3.00 µmol, 0.02 
equiv), AgX (3.00 µmol, 0.02 equiv), ligand 4e (3.75 µmol, 0.025 equiv) and dry PhCl (1 mL). 
The resulting solution was stirred at room temperature for 30 minutes. To this solution was added 
a mixture of 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) (0.15 mmol, 1.0 
equiv) and ethyl 2-diazoacetate (1a) (0.30 mmol, 2.0 equiv) in dry PhCl (2 mL) in 2 min and the 
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resulting reaction mixture was stirred until the reaction was completed (monitored by TLC, 
EtOAc:pentane, 1:40 v/v), the solvent was evaporated under reduced pressure and the crude 
product was purified by column chromatography (EtOAc:pentane, 1:40 v/v) directly without any 
further work-up. 
 
Entry CuX/AgX Time  Yield (%) ee 
1 CuCl/AgSbF6 1 h 95 83 
2 CuCl/AgClO4 24 h <5 nd 
3 CuCl/AgOTf 2 h 88 80 
4 CuCl/AgOTs 24 h <5 nd 
5 CuCl/AgNTf2 2 h 91 84 
6 CuCl/AgBF4 3 h 93 80 
7 CuCl/AgPF6 2 h 82 57 
8 CuBr/AgNTf2 2 h 90 83 
9 CuBr/ AgSbF6 20 h 91 83 
10 CuCl/ NaBARF 20 h <5 nd 
 
d) Screening of equivalents of diazo and TIPS-EBX 
A flame dried 5 mL microwave vial was charged under nitrogen with CuCl (3 µmol, 0.02 equiv), 
AgNTf2 (3.00 µmol, 0.02 equiv), ligand 4e (3.75 µmol, 0.025 equiv) and dry PhCl (1 mL). The 
resulting solution was stirred at room temperature for 30 minutes. To this solution was added a 
mixture of 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) and ethyl 2-
diazoacetate (1a) in dry PhCl (2 mL) in 2 min and the resulting reaction mixture was stirred until 
the reaction was completed (monitored by TLC, EtOAc:pentane, 1:40 v/v), the solvent was 
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evaporated under reduced pressure and the crude product was purified by column chromatography 
(EtOAc:pentane, 1:40 v/v) directly without any further work-up. 
 
Entry 1a (equiv) 2a (equiv) Time Yield (%) ee 
1 1.2 1 24 h 60 84 
2 2 1 2 h 91 84 
3 1 1.2 24 h 61 84 
 
e) Screening of concentration 
A flame dried 5 mL microwave vial was charged under nitrogen with CuCl (3.00 µmol, 0.02 equiv), 
AgNTf2 (3.00 µmol, 0.02 equiv), ligand 4e (3.75 µmol, 0.025 equiv) and dry PhCl. The resulting 
solution was stirred at room temperature for 30 minutes. To this solution was added a mixture of 
1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) (0.15 mmol, 1.0 equiv) and ethyl 
2-diazoacetate (1a) (0.30 mmol, 2.0 equiv) in dry PhCl in 2 min and the resulting reaction mixture 
was stirred until the reaction was completed (monitored by TLC, EtOAc:pentane, 1:40 v/v), the 
solvent was evaporated under reduced pressure and the crude product was purified by column 
chromatography (EtOAc:pentane, 1:40 v/v) directly without any further work-up. 
 
Entry Concentration (x M) Time Yield (%) ee 
1 0.05 M 2 h 91 84 
2 0.025 M 18 h 95 90 
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6. Copper catalyzed synthesis of chiral propargylic esters 
General procedure A:  
 
A flame dried 20 mL microwave vial was charged under nitrogen with CuCl (0.3 mg, 3 µmol, 0.02 
equiv), AgNTf2 (1.2 mg, 3.0 µmol, 0.02 equiv), ligand 4e (1.4 mg, 3.8 µmol, 0.025 equiv) and dry 
PhCl (1 mL). The resulting solution was stirred at room temperature for 1 h and then added to a 
mixture of R-EBX 2 (0.15 mmol, 1.0 equiv) and diazo compound 1 (0.30 mmol, 2.0 equiv) in dry 
PhCl (5 mL) in 2 min and the resulting reaction mixture was stirred at 25 °C for 18 h. After the 
reaction was completed (monitored by TLC, EtOAc;pentane or Et2O:pentane), the solvent was 
evaporated under reduced pressure and the crude product was purified by column chromatography 
(EtOAc:pentane or Et2O:pentane) directly without any further work-up. 
General procedure B:  
 
A flame dried 20 mL microwave vial was charged under nitrogen with CuCl (0.3 mg, 3 µmol, 0.02 
equiv), AgNTf2 (1.2 mg, 3.0 µmol, 0.02 equiv), ligand 4e (1.4 mg, 3.8 µmol, 0.025 equiv) and dry 
PhCl (1 mL). The resulting solution was stirred at room temperature for 1 h and then added to a 
mixture of R-EBX 2 (0.15 mmol, 1.0 equiv) and diazo compound 1 (0.30 mmol, 2.0 equiv) in dry 
PhCl (5 mL) in 2 min and the resulting reaction mixture was stirred at 35 °C for 18 h. After the 
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reaction was completed (monitored by TLC, EtOAc;pentane or Et2O:pentane, or toluene:pentane), 
the solvent was evaporated under reduced pressure and the crude product was purified by column 
chromatography (Et2O:pentane or toluene:pentane) directly without any further work-up. 
General procedure C:  
 
A flame dried 20 mL microwave vial was charged under nitrogen with CuCl (0.3 mg, 3 µmol, 0.02 
equiv), AgNTf2 (1.2 mg, 2.0 µmol, 0.02 equiv), ligand ent-4e (1.4 mg, 3.8 µmol, 0.025 equiv) and 
dry PhCl (1 mL). The resulting solution was stirred at room temperature for 1 h and then added to 
a mixture of R-EBX 2 (0.15 mmol, 1.0 equiv) and diazo compound 1 (0.30 mmol, 2.0 equiv) in 
dry PhCl (5 mL) in 2 min and the resulting reaction mixture was stirred at 25 °C for 18 h. After the 
reaction was completed (monitored by TLC, EtOAc;pentane or Et2O:pentane), the solvent was 
evaporated under reduced pressure and the crude product was purified by column chromatography 
(EtOAc:pentane or Et2O:pentane) directly without any further work-up. 
 
(R)-1-Ethoxy-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3a) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and ethyl 2-diazoacetate (1a) (36 µL, 0.30 mmol, 13 wt. % 
dichloromethane, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in 
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vacuo and purified by flash chromatography using EtOAc:pentane 1:40 as mobile phase to afford 
3a (73.0 mg, 0.142 mmol, 95%) as a colorless oil. TLC (EtOAc:pentane, 1:40 v/v): Rf = 0.14, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (dd, J = 7.9, 1.2 Hz, 1H, ArH), 7.99 (dd, J = 7.8, 1.7 
Hz, 1H, ArH), 7.44 (td, J = 7.6, 1.2 Hz, 1H, ArH), 7.18 (td, J = 7.7, 1.7 Hz, 1H, ArH), 5.98 (s, 1H, 
OCHCC), 4.44–4.17 (m, 2H, CH2CH3), 1.32 (t, J = 7.1 Hz, 3H, CH2CH3), 1.11–1.03 (m, 21H, 
TIPS); 13C NMR (100 MHz, CDCl3): δ 165.4, 164.9, 141.5, 133.3, 133.2, 131.8, 128.0, 97.6, 94.5, 
90.6, 63.9, 62.6, 18.5, 14.0, 11.0; IR ν 2945 (m), 2866 (m), 2188 (w), 1745 (s), 1583 (w), 1464 
(m), 1241 (s), 1203 (s), 1092 (s), 1020 (s), 883 (m); HRMS (ESI) calcd. for C22H32IO4Si+ [M+H]+ 
515.1109; found 515.1095; Chiral HPLC conditions: ee = 90%, Chiralpak IB 99.75:0.25 
Hexane/iPrOH, 1 mL/min, 30 min. tr (minor) = 18.7 min. and tr (major) = 22.8 min. λ = 250 cm-1; 
[α]D 25.0 = ‐28.9 (c = 0.5, CHCl3). 
 
(R)-1-(Benzyloxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3b) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and benzyl 2-diazoacetate (1b) (59.0 mg, 0.300 mmol, 10 wt 
% dichloromethane, 2.00 equiv) were stirred for 18 h. The crude reaction mixture was concentrated 
in vacuo and purified by flash chromatography using EtOAc:pentane 1:60 as mobile phase to afford 
3b (81.0 mg, 0.140 mmol, 94%) as a colorless oil. TLC (EtOAc:pentane, 1:40 v/v): Rf = 0.29, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (dd, J = 7.9, 1.1 Hz, 1H, ArH), 7.97 (dd, J = 7.8, 1.7 
Hz, 1H, ArH), 7.43 (td, J = 7.6, 1.2 Hz, 1H, ArH), 7.39–7.32 (m, 5H, ArH), 7.19 (td, J = 7.7, 1.7 
Hz, 1H, ArH), 6.05 (s, 1H, OCHCC), 5.35 (d, J = 12.2 Hz, 1H, ArCH2), 5.20 (d, J = 12.2 Hz, 1H, 
ArCH2), 1.07–1.00 (m, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 165.3, 164.9, 141.5, 134.8, 
133.3, 133.2, 131.9, 128.6, 128.5, 128.3, 128.0, 97.2, 94.6, 90.9, 68.0, 63.9, 18.5, 11.0; IR ν 2943 
(m), 2865 (m), 2189 (w), 1763 (s), 1741 (s), 1584 (w), 1463 (m), 1381 (w), 1324 (m), 1242 (s), 
1192 (s), 1094 (s), 1016 (s), 883 (m); HRMS (ESI) calcd. for C27H33INaO4Si+ [M+Na]+ 599.1085; 
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found 599.1092; Chiral HPLC conditions: ee = 89%, Chiralpak IB 95:5 Hexane/iPrOH, 1 mL/min, 
30 min. tr (major) = 5.6 min. and tr (minor) = 7.0 min. λ = 250 cm-1; [α]D 25.0 = ‐9.3 (c = 0.5, CHCl3). 
 
(R)-1-(Tert-butoxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3c) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and tert-butyl 2-diazoacetate (1c) (49 µL, 0.30 mmol, 15 wt. % 
dichloromethane, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in 
vacuo and purified by flash chromatography using EtOAc:pentane 1:60 as mobile phase to afford 
3c (75.0 mg, 0.138 mmol, 92%) as a colorless oil. TLC (EtOAc:pentane, 1:40 v/v): Rf = 0.25, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.04–7.97 (m, 2H, ArH), 7.43 (td, J = 7.6, 1.2 Hz, 1H, 
ArH), 7.18 (td, J = 7.7, 1.7 Hz, 1H, ArH), 5.87 (s, 1H, OCHCC), 1.51 (s, 9H, C(CH3)3), 1.09 (s, 
21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 165.0, 164.2, 141.5, 133.6, 133.2, 131.9, 128.0, 98.2, 
94.5, 89.8, 83.6, 64.4, 27.8, 18.5, 11.1; IR ν 2944 (m), 2867 (m), 2188 (w), 1744 (s), 1584 (w), 
1465 (m), 1371 (m), 1245 (s), 1158 (s), 1097 (s), 1017 (m), 881 (w), 846 (w); HRMS (ESI) calcd. 
for C24H35INaO4Si+ [M+Na]+ 565.1242; found 565.1245; Chiral HPLC conditions: ee = 89%; 
Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.5 mL/min, 31 min. tr (minor) = 14.1 min. and tr (major) 







Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,4-dimethylpentan-3-yl 2-diazoacetate (1d) (56 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using Et2O:pentane 1:60 as mobile phase to afford 3d (87.0 mg, 
0.149 mmol, 99%.) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 v/v): Rf = 0.24, KMnO4; 
1H NMR (400 MHz, CDCl3): δ 8.00 (t, J = 7.9 Hz, 2H, ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 7.18 
(t, J = 7.1 Hz, 1H, ArH), 6.02 (s, 1H, OCHCC), 4.70 (t, J = 6.1 Hz, 1H, iPr2CH), 1.97 (dp, J = 13.3, 
6.6 Hz, 2H, 2 X CH(CH3)2), 1.08 (s, 21H, TIPS), 0.94 (s, 6H, CH(CH3)2), 0.92 (s, 6H, CH(CH3)2); 
13C NMR (100 MHz, CDCl3): δ 165.5, 165.0, 141.4, 133.7, 133.1, 131.8, 127.9, 97.7, 94.4, 90.4, 
85.7, 64.0, 29.6, 29.5, 19.5, 19.4, 18.5, 17.3, 16.9, 11.0; IR ν 2962 (s), 2871 (m), 2727 (w), 2188 
(w), 1732 (s), 1578 (w), 1465 (m), 1380 (m), 1246 (s), 1126 (m), 1094 (s), 1010 (s), 890 (m); 
HRMS (ESI) calcd. for C27H41INaO4Si+ [M+Na]+ 607.1711; found 607.1706; Chiral HPLC 
conditions: ee = 92%; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.3 mL/min, 31 min. tr (minor) = 
21.3 min. and tr (major) = 22.6 min. λ = 250 cm-1; [α]D 25.0 = ‐16.9 (c = 0.5, CHCl3). 
 
(R)-1-(Dicyclohexylmethoxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3e) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,2'-(cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-
indeno[1,2-d]oxazole) (1e) (79 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction 
mixture was concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:60 
as mobile phase to afford 3e (100 mg, 0.150 mmol, quant.) as a colorless thick liquid. TLC 
(Et2O:pentane, 1:40 v/v): Rf = 0.26, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02–7.98 (m, J = 7.3 
Hz, 2H, ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.7 Hz, 1H, ArH), 6.02 (s, 1H, OCHCC), 
4.74 (t, J = 5.9 Hz, 1H, (Cy)2CH), 1.91–1.52 (m, 12H, 2 X Cy–CH and 5 X Cy–CH2), 1.39–0.93 
(m, 31H, TIPS and 5 X Cy–CH2); 13C NMR (100 MHz, CDCl3): δ 165.4, 164.9, 141.5, 133.6, 
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133.1, 131.9, 127.9, 97.8, 94.5, 90.3, 84.4, 63.9, 38.4, 29.7, 29.6, 27.2, 27.2, 26.3, 26.2, 26.2, 26.0, 
26.0, 18.5, 11.1; IR ν 2928 (s), 2855 (s), 2189 (w), 1743 (s), 1578 (w), 1453 (m), 1244 (s), 1091 
(s), 1015 (m), 989 (m), 929 (w), 888 (m); HRMS (ESI) calcd. for C33H49INaO4Si+ [M+Na]+ 
687.2337; found 687.2337; Chiral HPLC conditions: ee = 86%; Chiralpak IB 99.75:0.25 
Hexane/iPrOH, 0.3 mL/min, 31 min. tr (major) = 21.2 min. and tr (minor) = 25.7 min. λ = 280 cm-





Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2-phenylpropan-2-yl 2-diazoacetate (1f) (62 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using EtOAc:pentane 1:60 as mobile phase to afford 3f (78.0 
mg, 0.129 mmol, 86%) as a colorless thick liquid. TLC (EtOAc:pentane, 1:25 v/v): Rf = 0.4, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.88 (d, J = 7.9 Hz, 1H, ArH), 7.84 (d, J = 7.8 Hz, 1H, 
ArH), 7.30 (t, J = 7.7 Hz, 3H, ArH), 7.21 (t, J = 7.5 Hz, 2H, ArH), 7.15 (t, J = 3.6 Hz, 1H, ArH), 
7.05 (t, J = 7.6 Hz, 1H, ArH), 5.89 (s, 1H, OCHCC), 1.74 (s, 3H, CH3), 1.70 (s, 3H, CH3), 1.01 (s, 
21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 164.9, 163.4, 144.8, 141.4, 133.4, 133.1, 131.9, 128.3, 
127.9, 127.2, 124.1, 97.7, 94.5, 90.2, 84.6, 64.2, 28.9, 28.0, 18.6, 11.1; IR ν 2951 (m), 2866 (m), 
2189 (w), 1744 (s), 1579 (w), 1461 (m), 1240 (s), 1133 (s), 1095 (s), 1014 (m), 884 (w); HRMS 
(ESI) calcd. for C29H37INaO4Si+ [M+Na]+ 627.1398; found 627.1399; Chiral HPLC conditions: ee 
= 87%; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 1 mL/min, 30 min. tr (major) = 11.6 min. and tr 
(minor) = 13.1 min. λ = 250 cm-1; [α]D 25.0 = ‐29.1 (c = 0.5, CHCl3). 
 




Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and adamantan-1-yl 2-diazoacetate (1g) (66 mg, 0.30 mmol, 
2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and purified 
by flash chromatography using Et2O:pentane 1:60 as mobile phase to afford 3g (87.0 mg, 0.140 
mmol, 93%) as a white foam. Mp: 85.0–86.5 °C; TLC (Et2O:pentane, 1:40 v/v): Rf = 0.13, KMnO4; 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 3.6 Hz, 1H, ArH), 7.99 (d, J = 3.4 Hz, 1H, ArH), 7.43 
(t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.6 Hz, 1H, ArH), 5.87 (s, 1H, OCHCC), 2.22–2.12 (m, 9H, 
3 X CH and 3 X CH2), 1.72–1.62 (m, 6H, 3 X CH2), 1.09 (s, 21H, TIPS); 13C NMR (100 MHz, 
CDCl3): δ 165.0, 163.8, 141.4, 133.6, 133.1, 131.9, 128.0, 98.3, 94.5, 89.7, 83.7, 64.4, 41.0, 36.0, 
30.9, 18.6, 11.1; IR ν 2918 (s), 2864 (s), 2189 (w), 1743 (s), 1582 (w), 1461 (m), 1323 (m), 1244 
(s), 1210 (s), 1090 (s), 1053 (s), 881 (w); HRMS (ESI) calcd. for C30H41INaO4Si+ [M+Na]+ 
643.1711; found 643.1707; Chiral HPLC conditions: ee = 85%; Chiralpak IB 99:1 Hexane/iPrOH, 
0.5 mL/min, 20 min. tr (major) = 9.8 min. and tr (minor) = 10.7 min. λ = 250 cm-1; [α]D 25.0 = ‐10.2 





Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,3,4-trimethylpentan-3-yl 2-diazoacetate (1h) (60 mg, 
0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo 
and purified by flash chromatography using Et2O:pentane 1:60 as mobile phase to afford 3h (85.0 
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mg, 0.142 mmol, 95%) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 v/v): Rf = 0.36, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.00 (d, J = 7.9 Hz, 2H, ArH), 7.42 (t, J = 7.6 Hz, 1H, 
ArH), 7.17 (t, J = 7.6 Hz, 1H, ArH), 5.89 (s, 1H, OCHCC), 2.37–2.24 (m, 2H, 2 X CH(CH3)2), 
1.47 (s, 3H, OCCH3), 1.08 (s, 21H, TIPS), 1.03–0.95 (m, 12H, 2 X CH(CH3)2); 13C NMR (100 
MHz, CDCl3): δ 165.0, 164.1, 141.4, 133.6, 133.1, 131.9, 127.9, 98.1, 94.6, 94.5, 89.7, 64.4, 34.5, 
34.4, 18.5, 18.1, 18.1, 17.8, 17.7, 11.0; IR ν 2950 (s), 2870 (m), 2188 (w), 1746 (s), 1579 (w), 1465 
(m), 1384 (w), 1240 (s), 1095 (s), 1015 (m), 887 (w); HRMS (ESI) calcd. for C28H43INaO4Si+ 
[M+Na]+ 621.1868; found 621.1869; Chiral HPLC conditions: ee = 92%; Chiralpak IC 99.75:0.25 
Hexane/iPrOH, 0.4 mL/min, 60 min. tr (major) = 34.6 min. and tr (minor) = 46.4 min. λ = 254 cm-
1; [α]D 25.0 = ‐14.1 (c = 0.5, CHCl3). One carbon was not resolved at 100 MHz. 
 
(R)-1-(2,6-Diisopropylphenoxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3i) 
 
Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-diisopropylphenyl 2-diazoacetate (1i) (74 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using Et2O:pentane 1:70 as mobile phase to afford 3i (95.0 mg, 
0.147 mmol, 98%) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 v/v): Rf = 0.39, KMnO4; 
1H NMR (400 MHz, CDCl3): δ 8.06 (d, J = 8.0 Hz, 1H, ArH), 8.02 (d, J = 7.8 Hz, 1H, ArH), 7.47 
(t, J = 7.6 Hz, 1H, ArH), 7.28 (d, J = 5.5 Hz, 1H, ArH), 7.24–7.20 (m, 3H, ArH), 6.34 (s, 1H, 
OCHCC), 3.18–3.11 (m, 2H, 2 X CH(CH3)2), 1.31–1.21 (m, 12H, 2 X CH(CH3)2), 1.17 (s, 21H, 
TIPS); 13C NMR (100 MHz, CDCl3): δ 164.9, 164.2, 144.8, 141.5, 140.5, 133.3, 133.2, 131.8, 
128.0, 127.0, 124.1, 96.6, 94.5, 91.5, 63.8, 27.0, 23.8, 23.1, 18.5, 11.1; IR ν 2960 (s), 2871 (m), 
2189 (w), 1779 (m), 1741 (m), 1579 (w), 1463 (m), 1323 (m), 1240 (s), 1171 (s), 1087 (s), 1013 
(m), 884 (w); HRMS (ESI) calcd. for C32H44IO4Si+ [M+H]+ 647.2048; found 647.2043; Chiral 
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HPLC conditions: ee = 90%; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.5 mL/min, 31 min. tr 





Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methoxyphenyl 2-diazoacetate (1j) (91 
mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in 
vacuo and purified by flash chromatography using Et2O:pentane 1:25 as mobile phase to afford 3j 
(104 mg, 0.148 mmol, 98%) as a colorless thick liquid. TLC (Et2O:pentane, 1:25 v/v): Rf = 0.16, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 7.9 Hz, 1H, ArH), 7.93 (d, J = 7.8 Hz, 1H, 
ArH), 7.42 (t, J = 7.6 Hz, 1H, ArH), 7.19 (t, J = 7.6 Hz, 1H, ArH), 6.87 (s, 2H, ArH), 6.59 (s, 1H, 
OCHCC), 3.79 (s, 3H, OCH3), 1.37 (s, 18H, 2 X C(CH3)3), 1.10 (s, 21H, TIPS); 13C NMR (100 
MHz, CDCl3): δ 165.7, 164.5, 156.6, 143.7, 143.3, 141.5, 141.4, 133.7, 133.2, 131.5, 127.9, 111.7, 
97.1, 94.5, 91.9, 64.0, 55.2, 35.7, 35.6, 31.6, 31.4, 18.5, 11.1; IR ν 2954 (s), 2870 (m), 2188 (w), 
1774 (s), 1747 (s), 1592 (m), 1463 (m), 1425 (m), 1309 (m), 1239 (s), 1179 (s), 1094 (s), 1012 (m), 
879 (w); HRMS (ESI) calcd. for C35H49INaO5Si+ [M+Na]+ 727.2286; found 727.2294; Chiral 
HPLC conditions: ee = 95%; Chiralpak IA 99:1 Hexane/iPrOH, 0.2 mL/min, 60 min. tr (major) = 
32.1 min. and tr (minor) = 48.4 min. λ = 254 cm-1; [α]D 25.0 = ‐28.0 (c = 0.5, CHCl3). One carbon 







Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 
mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in 
vacuo and purified by flash chromatography using Et2O:pentane 1:60 as mobile phase to afford 3k 
(103 mg, 0.150 mmol, quant.) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 v/v): Rf = 0.3, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (dd, J = 8.0, 1.1 Hz, 1H, ArH)), 7.92 (dd, J = 7.8, 1.7 
Hz, 1H, ArH)), 7.41 (td, J = 7.7, 0.9 Hz, 1H, ArH)), 7.18 (td, J = 7.7, 1.7 Hz, 1H, ArH)), 7.13 (s, 
2H, ArH)), 6.59 (s, 1H, OCHCC), 2.32 (s, 3H, ArCH3), 1.36 (s, 18H, 2 X C(CH3)3), 1.10 (s, 21H, 
TIPS); 13C NMR (100 MHz, CDCl3): δ 165.5, 164.5, 145.7, 142.1, 141.8, 141.4, 135.2, 133.7, 
133.1, 131.5, 127.9, 127.2, 97.1, 94.4, 91.9, 64.0, 35.4, 35.3, 31.7, 31.6, 21.5, 18.5, 11.1; IR ν 2945 
(m), 2866 (m), 1773 (s), 1746 (s), 1584 (w), 1465 (m), 1366 (w), 1271 (m), 1239 (s), 1183 (s), 
1130 (m), 1094 (s), 1017 (s), 998 (w), 921 (w), 885 (m); HRMS (ESI) calcd. for C35H49INaO4Si+ 
[M+Na]+ 711.2337; found 711.2341; Chiral HPLC conditions: ee = 97%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 0.5 mL/min, 30 min. tr (major) = 11.6 min. and tr (minor) = 15.0 min. λ = 250 cm-1; 
[α]D 25.0 = ‐26.4 (c = 0.5, CHCl3). One carbon was not resolved at 100 MHz. 
 
Large scale procedure: 
1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) (643 mg, 1.50 mmol, 1.00 equiv) 
and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (865 mg, 3.00 mmol, 2.00 equiv) were 
stirred for 18 h. The crude reaction mixture was concentrated in vacuo and purified by flash 
chromatography using Et2O:pentane 1:60 as mobile phase to afford 3k (1.01 g, 0.147 mmol, 98%) 
as a colorless thick liquid. Chiral HPLC conditions: ee = 95%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 0.5 mL/min, 30 min. tr (major) = 11.6 min. and tr (minor) = 15.0 min. λ = 250 cm-




(S)-1-(Ethoxysulfonyl)-3-(triisopropylsilyl)prop-2-yn-1-yl 2-iodobenzoate (3l) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and ethyl diazomethanesulfonate (1l) (45 mg, 0.30 mmol, 2.0 
equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and purified by 
flash chromatography using EtOAc:pentane 1:20 as mobile phase to afford 3l (82.0 mg, 0.149 
mmol, 99%) as a colorless oil. TLC (EtOAc:pentane, 1:20 v/v): Rf = 0.3, KMnO4; 1H NMR (400 
MHz, CDCl3): δ 8.05 (dd, J = 7.9, 1.2 Hz, 1H, ArH), 7.94 (dd, J = 7.8, 1.7 Hz, 1H, ArH), 7.46 (td, 
J = 7.6, 1.2 Hz, 1H, ArH), 7.23 (td, J = 7.7, 1.7 Hz, 1H, ArH), 6.71 (s, 1H, OCHCC), 4.51 (q, J = 
7.1 Hz, 2H, CH2CH3), 1.43 (t, J = 7.1 Hz, 3H, CH2CH3), 1.13–1.07 (m, 21H, TIPS); 13C NMR (100 
MHz, CDCl3): δ 163.1, 141.8, 133.8, 132.2, 131.9, 128.2, 95.6, 94.9, 93.6, 73.9, 70.8, 18.5, 15.3, 
11.0; IR ν 2947 (m), 2868 (m), 1755 (s), 1584 (w), 1466 (m), 1383 (s), 1238 (s), 1180 (m), 1078 
(s), 1009 (m), 924 (s), 887 (w); HRMS (ESI) calcd. for C21H31INaO5SSi+ [M+Na]+ 573.0598; found 
573.0599; Chiral HPLC conditions: ee = 75%; Chiralpak IB 99:1 Hexane/iPrOH, 1 mL/min, 20 
min. tr (minor) = 8.0 min. and tr (major) = 9.0 min. λ = 254 cm-1; [α]D 25.0 = ‐14.3 (c = 0.5, CHCl3). 
 
(S)-1-(Diethoxyphosphoryl)-3-(triisopropylsilyl)prop-2-yn-1-yl 2-iodobenzoate (3m) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and diethyl (diazomethyl)phosphonate (1m) (54 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
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purified by flash chromatography using EtOAc:pentane 1:4 as mobile phase to afford 3m (82.0 
mg, 0.142 mmol, 94%) as a colorless oil. TLC (EtOAc:pentane, 1:4 v/v): Rf = 0.35, KMnO4; 1H 
NMR (400 MHz, CDCl3): δ 8.00 (dd, J = 8.0, 1.1 Hz, 1H, ArH), 7.84 (dd, J = 7.9, 1.7 Hz, 1H, 
ArH), 7.42 (td, J = 7.6, 1.1 Hz, 1H, ArH), 7.18 (td, J = 7.7, 1.6 Hz, 1H, ArH), 6.05 (d, J = 17.0 Hz, 
1H, OCHP), 4.35–4.18 (m, 4H, 2 X CH2CH3), 1.35 (td, J = 7.1, 3.5 Hz, 6H, 2 X CH2CH3), 1.08 (s, 
21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 164.4 (d, J = 8.0 Hz), 141.4, 133.8, 133.1, 131.4, 
127.9, 97.4 (d, J = 5.8 Hz), 94.4, 91.8 (d, J = 8.2 Hz), 64.1 (d, J = 6.9 Hz), 64.0 (d, J = 6.5 Hz), 
60.2 (d, J = 174.4 Hz), 18.5, 16.4 (m, 2 X C), 11.1; IR ν 2944 (w), 2866 (w), 2181 (w), 1744 (m), 
1464 (w), 1270 (m), 1241 (m), 1020 (s), 977 (m), 884 (w); HRMS (ESI) calcd. for C23H37IO5PSi+ 
[M+H]+ 579.1187; found 579.1195; Chiral HPLC conditions: ee = 90%; Chiralpak IB 99:1 
Hexane/iPrOH, 1 mL/min, 40 min. tr (major) = 28.9 min. and tr (minor) = 34.6 min. λ = 230 cm-1; 
[α]D 25.0 = ‐14.0 (c = 0.5, CHCl3). 
 
(R)-1-(Methoxy(methyl)amino)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (3n) 
 
Following general procedure B, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 2-diazo-N-methoxy-N-methylacetamide (1n) (39 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using Et2O:pentane 1:10 as mobile phase to afford 3n (65.0 mg, 
0.123 mmol, 82%) as a white foam. Mp: 44.2–46.5 °C; TLC (Et2O:pentane, 1:10 v/v): Rf = 0.34, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.06 (d, J = 7.8 Hz, 1H, ArH), 8.00 (d, J = 7.9 Hz, 1H, 
ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 7.17 (t, J = 7.7 Hz, 1H, ArH), 6.36 (s, 1H, OCHCC), 3.87 (s, 
3H, NOCH3), 3.26 (s, 3H, NCH3), 1.08 (s, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 165.6, 
165.2, 141.3, 133.4, 133.1, 132.1, 128.0, 98.2, 94.5, 90.3, 63.2, 61.5, 32.7, 18.5, 11.0; IR ν 2962 
(s), 2876 (m), 2185 (w), 1738 (m), 1698 (m), 1578 (w), 1463 (m), 1387 (m), 1246 (s), 1067 (s), 
987 (w), 887 (w); HRMS (ESI) calcd. for C22H33INO4Si+ [M+H]+ 530.1218; found 530.1226; 
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Chiral HPLC conditions: ee = 90%; Chiralpak IB 97:3 Hexane/iPrOH, 1 mL/min, 30 min. tr (minor) 





Following general procedure B, 5-methyl-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-
one (2b) (67.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate 
(1k) (87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:60 as mobile 
phase to afford 3o (104 mg, 0.148 mmol, 99%) as a white solid. Mp: 75.0–77.5 °C; TLC 
(Et2O:pentane, 1:60 v/v): Rf = 0.25, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.86 (d, J = 8.1 Hz, 
1H, ArH), 7.73 (d, J = 2.0 Hz, 1H, ArH), 7.13 (s, 2H, ArH), 7.00 (dd, J = 8.1, 2.1 Hz, 1H, ArH), 
6.58 (s, 1H, OCHCC), 2.32 (s, 3H, ArCH3), 2.31 (s, 3H, ArCH3), 1.37 (s, 18H, 2 X C(CH3)3), 1.10 
(s, 21H, TIPS). 13C NMR (100 MHz, CDCl3): δ 165.5, 164.6, 145.8, 142.1, 141.8, 141.1, 138.1, 
135.2, 134.2, 133.5, 132.3, 127.1, 97.2, 91.9, 90.3, 64.0, 35.4, 35.3, 31.7, 31.6, 21.5, 20.8, 18.5, 
11.1; IR ν 2955 (m), 2869 (m), 2239 (w), 2188 (w), 1744 (s), 1464 (m), 1187 (s), 1096 (s), 1011 
(m), 886 (m); HRMS (ESI) calcd. for C36H51INaO4Si+ [M+Na]+ 725.2494; found 725.2491; Chiral 
HPLC conditions: ee = 97%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 0.3 mL/min, 30 min. tr 
(major) = 19.3 min. and tr (minor) = 24.8 min. λ = 254 cm-1; [α]D 25.0 = ‐20.1 (c = 0.5, CHCl3). One 







Following general procedure B, 6-methyl-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-
one (2c) (67.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate 
(1k) (87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:60 as mobile 
phase to afford 3p (103 mg, 0.147 mmol, 98%) as a white foam. Mp: 49.2–52.5 °C; TLC 
(Et2O:pentane, 1:40 v/v): Rf = 0.22, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.66 (d, J = 7.9 Hz, 
1H, ArH), 7.17 (d, J = 7.7 Hz, 1H, ArH), 7.13 (s, 2H, ArH), 7.01 (t, J = 7.8 Hz, 1H, ArH), 6.63 (s, 
1H, OCHCC), 2.39 (s, 3H, ArCH3), 2.32 (s, 3H, ArCH3), 1.38 (s, 9H, C(CH3)3), 1.37 (s, 9H, 
C(CH3)3), 1.11 (s, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 167.1, 165.2, 145.7, 142.3, 141.8, 
138.4, 137.6, 136.4, 135.2, 131.0, 129.8, 127.2, 127.2, 96.5, 92.3, 91.7, 64.0, 35.4, 35.2, 31.8, 31.5, 
21.5, 20.0, 18.6, 11.1; IR ν 2952 (m), 2866 (m), 1775 (m), 1749 (s), 1464 (w), 1237 (m), 1184 (m), 
1092 (s), 1063 (s), 997 (w), 885 (w); HRMS (ESI) calcd. for C36H51INaO4Si+ [M+Na]+ 725.2494; 
found 725.2491; Chiral HPLC conditions: ee = 98%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 0.2 
mL/min, 40 min. tr (major) = 25.4 min. and tr (minor) = 27.3 min. λ = 273 cm-1; [α]D 25.0 = ‐55.8 





Following general procedure B, 5-fluoro-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-
one (2c) (67.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate 
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(1k) (87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 3q (104 mg, 0.147 mmol, 98%) as a colorless thick liquid. TLC (Et2O:pentane, 
1:60 v/v): Rf = 0.1, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.96 (dd, J = 8.7, 5.3 Hz, 1H, ArH), 
7.65 (dd, J = 8.9, 2.9 Hz, 1H, ArH), 7.13 (s, 2H, ArH), 6.96 (td, J = 8.3, 3.0 Hz, 1H, ArH), 6.56 (s, 
1H, OCHCC), 2.32 (s, 3H, ArCH3), 1.36 (s, 18H, 2 X C(CH3)3), 1.10 (s, 21H, TIPS); 13C NMR 
(100 MHz, CDCl3): δ 165.3, 163.4 (d, J = 2.0 Hz), 162.3 (d, J = 249.7 Hz), 145.7, 142.8 (d, J = 7.2 
Hz), 142.1, 141.7, 135.3, 135.2 (d, J = 7.0 Hz), 127.2, 120.9 (d, J = 21.6 Hz), 119.0 (d, J = 24.4 
Hz), 96.7, 92.4, 87.5 (d, J = 3.5 Hz), 64.3, 35.4, 35.3, 31.7, 31.6, 21.5, 18.5, 11.1; IR ν 2949 (m), 
2866 (m), 2189 (w), 1751 (m), 1597 (w), 1581 (w), 1465 (m), 1426 (w), 1271 (m), 1237 (m), 1183 
(s), 1077 (m), 1014 (m), 920 (w), 886 (m); HRMS (ESI) calcd. for C35H48FINaO4Si+ [M+Na]+ 
729.2243; found 729.2251; Chiral HPLC conditions: ee = 97%; Chiralpak IB 99.75:0.25 
Hexane/iPrOH, 0.4 mL/min, 31 min. tr (major) = 15.1 min. and tr (minor) = 16.3 min. λ = 254 cm-1; 





Following general procedure B, 6-fluoro-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-
one (2d) (67.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate 
(1k) (87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 3r (105 mg, 0.149 mmol, 99%) as a white foam. Mp: 41.5–43.3 °C; TLC 
(Et2O:pentane, 1:60 v/v): Rf = 0.1, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.72–7.58 (m, 1H, 
ArH), 7.20–7.05 (m, 4H, ArH), 6.56 (s, 1H, OCHCC), 2.32 (s, 3H, ArCH3), 1.37 (s, 9H, C(CH3)3), 
1.36 (s, 9H, C(CH3)3), 1.11 (s, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 164.8, 163.2, 159.4 (d, 
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J = 257.5 Hz), 145.7, 142.2, 141.8, 135.2 (d, J = 3.7 Hz), 135.2, 132.8 (d, J = 8.4 Hz), 127.2, 127.1, 
126.9 (d, J = 18.5 Hz), 115.8 (d, J = 21.2 Hz), 96.5, 92.5, 64.6, 35.4, 35.2, 31.7, 31.5, 21.5, 18.5, 
11.1; IR ν 2955 (s), 2868 (m), 2189 (w), 1755 (s), 1599 (m), 1569 (w), 1451 (s), 1256 (s), 1183 (s), 
1096 (s), 1058 (m), 996 (m), 864 (m); HRMS (ESI) calcd. for C35H48FINaO4Si+ [M+Na]+ 
729.2243; found 729.2251; Chiral HPLC conditions: ee = 95%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 0.3 mL/min, 30 min. tr (major) = 22.0 min. and tr (minor) = 24.4 min. λ = 280 cm-1; 





Following general procedure B, 5-nitro-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one 
(2e) (71.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) 
(87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated 
in vacuo and purified by flash chromatography using Et2O:pentane 1:30 as mobile phase to afford 
3s (110 mg, 0.150 mmol, quant.) as a pale yellow foam. Mp: 39.5–42.5 °C; TLC (Et2O:pentane, 
1:25 v/v): Rf = 0.15, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.71 (d, J = 2.7 Hz, 1H, ArH), 8.23 
(d, J = 8.6 Hz, 1H, ArH), 8.01 (dd, J = 8.6, 2.7 Hz, 1H, ArH), 7.13 (s, 2H, ArH), 6.57 (s, 1H, 
OCHCC), 2.32 (s, 3H, ArCH3), 1.38 (s, 9H, C(CH3)3), 1.37 (s, 9H, C(CH3)3), 1.13–1.09 (m, 21H, 
TIPS); 13C NMR (100 MHz, CDCl3): δ 165.0, 162.9, 147.7, 145.7, 142.9, 142.1, 141.7, 135.3, 
135.2, 127.2, 127.2, 126.8, 126.0, 102.8, 96.4, 93.0, 64.8, 35.4, 35.3, 31.7, 31.6, 21.5, 18.5, 11.1; 
IR ν 2952 (s), 2867 (m), 2354 (w), 1756 (s), 1603 (m), 1531 (s), 1465 (m), 1348 (s), 1233 (s), 1099 
(s), 1016 (m), 916 (m); HRMS (ESI) calcd. for C35H48INNaO6Si+ [M+Na]+ 756.2188; found 
756.2193; Chiral HPLC conditions: ee = 91%; Chiralpak IC 99:1 Hexane/iPrOH, 0.25 mL/min, 60 








Following general procedure B, 4,5-dimethoxy-1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-
3(1H)-one (2f) (73.5 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-
diazoacetate (1k) (87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture 
was concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:60 as 
mobile phase to afford 3t (106 mg, 0.142 mmol, 94%) as a white foam. Mp: 49.3–52.5 °C; TLC 
(Et2O:pentane, 1:40 v/v): Rf = 0.25, KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.56 (s, 1H, ArH), 
7.41 (s, 1H, ArH), 7.12 (s, 2H, ArH), 6.56 (s, 1H, OCHCC), 3.92 (s, 3H, OCH3), 3.84 (s, 3H, 
OCH3), 2.32 (s, 3H, ArCH3), 1.37 (s, 9H, C(CH3)3), 1.36 (s, 9H, C(CH3)3), 1.09 (s, 21H, TIPS); 
13C NMR (100 MHz, CDCl3): δ 165.7, 163.3, 152.4, 148.6, 145.7, 142.1, 141.7, 135.2, 127.2, 127.1 
124.7, 123.8, 114.2, 97.5, 91.5, 85.4, 63.8, 56.3, 55.8, 35.3, 35.3, 31.6, 31.6, 21.5, 18.5, 11.1; IR ν 
2952 (m), 2867 (w), 1773 (w), 1741 (m), 1592 (w), 1509 (m), 1464 (w), 1371 (w), 1340 (w), 1266 
(s), 1206 (s), 1176 (s), 1100 (s), 1009 (w), 883 (w); HRMS (ESI) calcd. for C37H53INaO6Si+ 
[M+Na]+ 771.2548; found 771.2557; Chiral HPLC conditions: ee = 97%; Chiralpak IA 99:1 
Hexane/iPrOH, 0.5 mL/min, 25 min. tr (major) = 14.7 min. and tr (minor) = 18.3 min. λ = 254 cm-1; 







Following general procedure B, 1-[(triethylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2g) (58.0 
mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 
0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo 
and purified by flash chromatography using Et2O:pentane 1:60 as mobile phase to afford 3u (74.0 
mg, 0.114 mmol, 78%) as a white solid. Mp: 98.5–102.0 °C; TLC (Et2O:pentane, 1:40 v/v): Rf = 
0.28, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 7.9 Hz, 1H, ArH), 7.95 (d, J = 7.3 Hz, 
1H, ArH), 7.41 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.9 Hz, 1H, ArH), 7.13 (s, 2H, ArH), 6.56 (s, 
1H, OCHCC), 2.32 (s, 3H, ArCH3), 1.37 (s, 9H, C(CH3)3), 1.37 (s, 9H, C(CH3)3), 1.01 (t, J = 7.9 
Hz, 9H, 3 X CH2CH3), 0.66 (q, J = 7.9 Hz, 6H, 3 X CH2CH3); 13C NMR (100 MHz, CDCl3): δ 
165.3, 164.5, 145.8, 142.1, 141.8, 141.4, 135.2, 133.7, 133.2, 131.7, 127.9, 127.2, 127.0, 96.2, 
94.5, 93.0, 64.0, 35.3, 35.3, 31.6, 31.6, 21.5, 7.3, 4.0; IR ν 2958 (m), 2879 (m), 2190 (w), 1938 
(w), 1775 (m), 1745 (s), 1589 (w), 1464 (m), 1424 (m), 1238 (s), 1184 (s), 1094 (s), 1013 (s), 864 
(w); HRMS (ESI) calcd. for C32H44IO4Si+ [M+H]+ 647.2048; found 647.2054; Chiral HPLC 
conditions: ee = 94%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 0.5 mL/min, 30 min. tr (major) = 
12.0 min. and tr (minor) = 16.4 min. λ = 254 cm-1; [α]D 25.0 = ‐27.6 (c = 0.5, CHCl3).  
 
(R)-7-Chloro-1-(2,6-di-tert-butyl-4-methylphenoxy)-1-oxohept-3-yn-2-yl 2-iodobenzoate (3v) 
 
Following general procedure B, (5-chloropent-1-ynyl)-1,2-benziodoxol-3(1H)-one (2h) (52.5 mg, 
0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
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purified by flash chromatography using EtOAc:pentane 1:50 as mobile phase to afford 3v (85 mg, 
0.14 mmol, 93%) as a colorless thick liquid. TLC (EtOAc:pentane, 1:40 v/v): Rf = 0.18, KMnO4; 
1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 7.9 Hz, 1H, ArH), 7.97 (d, J = 7.8 Hz, 1H, ArH), 7.41 
(t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.7 Hz, 1H, ArH), 7.14 (s, 1H, ArH), 7.13 (s, 1H, ArH), 6.51 
(s, 1H, OCHCC), 3.67 (t, J = 6.3 Hz, 2H, ClCH2CH2), 2.57–2.50 (m, 2H, CCCH2CH2), 2.32 (s, 
3H, ArCH3), 2.03 (p, J = 6.5 Hz, 2H, ClCH2CH2), 1.37 (s, 9H, C(CH3)3), 1.36 (s, 9H, C(CH3)3); 
13C NMR (100 MHz, CDCl3): δ 165.6, 164.6, 145.7, 142.0, 141.9, 141.4, 135.2, 133.6, 133.2, 
131.7, 127.9, 127.3, 127.0, 94.5, 88.5, 72.5, 63.8, 43.4, 35.3, 35.3, 31.6, 31.3, 30.8, 21.5, 16.3; IR 
ν 2961 (m), 2870 (w), 2250 (w), 1778 (s), 1745 (s), 1466 (w), 1428 (m), 1241 (s), 1185 (s), 1097 
(s), 1042 (w), 1013 (m), 862 (w); HRMS (ESI) calcd. for C29H34ClINaO4+ [M+Na]+ 631.1083; 
found 631.1088; Chiral HPLC conditions: ee = 92%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 1 
mL/min, 30 min. tr (major) = 12.8 min. and tr (minor) = 16.4 min. λ = 250 cm-1; [α]D 25.0 = ‐23.8 (c 
= 0.5, CHCl3). 
 
(R)-1-(2,6-Di-tert-butyl-4-methylphenoxy)-1-oxooctadec-3-yn-2-yl 2-iodobenzoate (3w) 
 
Following general procedure B, hexadecynyl-1,2-benziodoxol-3(1H)-one (2i) (70.5 mg, 0.150 
mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 0.30 mmol, 
2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and purified 
by flash chromatography using Et2O:pentane 1:40 as mobile phase to afford 3w (90.0 mg, 0.123 
mmol, 82%) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 v/v): Rf = 0.1, KMnO4; 1H NMR 
(400 MHz, CDCl3): δ 8.00 (dd, J = 7.9, 0.9 Hz, 1H, ArH), 7.97 (dd, J = 7.8, 1.6 Hz, 1H, ArH), 7.40 
(td, J = 7.7, 1.1 Hz, 1H, ArH), 7.17 (td, J = 7.7, 1.7 Hz, 1H, ArH), 7.14–7.11 (m, 2H, ArH), 6.51 
(t, J = 2.2 Hz, 1H, OCHCC), 2.38–2.26 (m, 5H, ArCH3 and CCCH2), 1.62–1.52 (m, 2H, CH2), 1.38 
(s, 9H, C(CH3)3), 1.36 (s, 9H, C(CH3)3), 1.33–1.19 (m, 22H), 0.88 (t, J = 6.8 Hz, 3H, CH2CH3); 
13C NMR (100 MHz, CDCl3): δ 165.8, 164.6, 145.8, 142.1, 142.0, 141.4, 135.1, 133.7, 133.1, 
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131.7, 127.9, 127.3, 126.9, 94.5, 90.7, 71.3, 64.0, 35.3, 35.3, 31.9, 31.6, 31.3, 29.7, 29.7, 29.6, 
29.5, 29.4, 29.1, 28.9, 28.0, 22.7, 21.5, 18.9, 14.1; IR ν 2925 (s), 2856 (m), 2247 (w), 1777 (m), 
1744 (s), 1465 (m), 1428 (w), 1368 (w), 1242 (s), 1184 (s), 1097 (s), 1044 (w), 1015 (m), 863 (w); 
HRMS (ESI) calcd. for C40H57INaO4+ [M+Na]+ 751.3194; found 751.3175; Chiral HPLC 
conditions: ee = 93%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 0.5 mL/min, 30 min. tr (major) = 
16.6 min. and tr (minor) = 21.0 min. λ = 250 cm-1; [α]D 25.0 = ‐20.3 (c = 0.5, CHCl3). Two carbons 





Following general procedure B, 8-(trimethylsilyl)octa-1,7-diyn-1-yl-1,2-benziodoxol-3(1H)-one 
(2j) (64.0 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) 
(87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated 
in vacuo and purified by flash chromatography using Et2O:pentane 1:30 as mobile phase to afford 
3x (86.0 mg, 0.126 mmol, 84%) as a colorless thick liquid. TLC (Et2O:pentane, 1:20 v/v): Rf = 
0.25, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.00 (dd, J = 7.9, 0.9 Hz, 1H, ArH), 7.97 (dd, J = 
7.8, 1.7 Hz, 1H, ArH), 7.40 (td, J = 7.7, 1.1 Hz, 1H, ArH), 7.17 (td, J = 7.6, 1.7 Hz, 1H, ArH), 
7.15–7.10 (m, 2H, ArH), 6.50 (t, J = 2.2 Hz, 1H, OCHCC), 2.38–2.36 (m, 2H, TMSCCCH2), 2.32 
(s, 3H, ArCH3), 2.25 (t, J = 6.7 Hz, 2H, CHCCCH2), 1.69–1.64 (m, 4H,CH2CH2CH2CH2), 1.37 (s, 
9H, C(CH3)3), 1.36 (s, 9H, C(CH3)3), 0.14 (s, 9H, TMS); 13C NMR (100 MHz, CDCl3): δ 165.7, 
164.6, 145.8, 142.0, 141.9, 141.4, 135.1, 133.7, 133.1, 131.7, 127.9, 127.3, 127.0, 106.7, 94.5, 
90.0, 84.9, 71.7, 63.9, 35.3, 35.3, 31.6, 31.3, 27.6, 27.0, 21.5, 19.4, 18.5, 0.2; IR ν 2959 (m), 2867 
(w), 2248 (w), 2174 (w), 1776 (s), 1744 (s), 1590 (w), 1465 (w), 1427 (m), 1368 (w), 1245 (s), 
1184 (s), 1098 (s), 1016 (m); HRMS (ESI) calcd. for C35H45INaO4Si+ [M+Na]+ 707.2024; found 
707.2022; Chiral HPLC conditions: ee = 90%; Chiralpak IA 99.75:0.25 Hexane/iPrOH, 1 mL/min, 
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Following general procedure B, 2-cyclopropylethynyl-1,2-benziodoxol-3(1H)-one (2k) (47.0 mg, 
0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using Et2O:pentane 1:30 as mobile phase to afford 3y (78.0 mg, 
0.136 mmol, 91%) as a white foam. Mp: 44.5–47.3 °C; TLC (Et2O:pentane, 1:30 v/v): Rf = 0.15, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 7.99 (t, J = 8.4 Hz, 2H, ArH), 7.40 (t, J = 7.6 Hz, 1H, 
ArH), 7.17 (t, J = 7.7 Hz, 1H, ArH), 7.13 (d, J = 4.8 Hz, 2H, ArH), 6.49–6.47 (m, 1H, OCHCC), 
2.32 (s, 3H, ArCH3), 1.38 (s, 9H, C(CH3)3), 1.36 (s, 10H, C(CH3)3 and cy-CH), 0.90–0.78 (m, 4H, 
cy-CH2); 13C NMR (100 MHz, CDCl3): δ 165.7, 164.6, 145.8, 142.1, 142.0, 141.3, 135.1, 133.7, 
133.1, 131.7, 127.9, 127.3, 126.9, 94.5, 93.5, 66.6, 64.0, 35.3, 35.3, 31.6, 31.3, 21.5, 8.2, 8.2, -0.4; 
IR ν 2961 (w), 2251 (w), 1774 (m), 1744 (s), 1590 (w), 1472 (w), 1427 (w), 1366 (w), 1242 (s), 
1187 (s), 1098 (s), 1011 (m), 918 (w), 863 (w); HRMS (ESI) calcd. for 
C29H33INaO4+ [M+Na]+ 595.1316; found 595.1320; Chiral HPLC conditions: ee = 89%; Chiralpak 
IA 99.75:0.25 Hexane/iPrOH, 0.3 mL/min, 60 min. tr (major) = 34.7 min. and tr (minor) = 47.1 
min. λ = 250 cm-1; [α]D 25.0 = ‐27.3 (c = 0.5, CHCl3). 
 




Following general procedure B, 1-[phenylethynyl]-1,2-benziodoxol-3(1H)-one (2l) (52.5 mg, 
0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 0.30 
mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo and 
purified by flash chromatography using toluene:pentane 1:1 as mobile phase to afford 3z (89.0 mg, 
0.146 mmol, 98%) as a white foam. Mp: 50.0–52.5 °C;TLC (toluene:pentane, 1:1 v/v): Rf = 0.36, 
KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (dd, J = 7.6, 1.4 Hz, 2H, ArH), 7.57–7.50 (m, 2H, 
ArH), 7.46–7.31 (m, 4H, ArH), 7.18 (td, J = 7.7, 1.7 Hz, 1H, ArH), 7.16–7.11 (m, 2H, ArH), 6.76 
(s, 1H, OCHCC), 2.33 (s, 3H, ArCH3), 1.39 (s, 9H, C(CH3)3), 1.39 (s, 9H, C(CH3)3). 13C NMR 
(100 MHz, CDCl3): δ 165.4, 164.6, 145.8, 142.1, 142.0, 141.4, 135.2, 133.5, 133.2, 132.1, 131.8, 
129.3, 128.4, 128.0, 127.4, 127.0, 121.4, 94.6, 88.9, 80.1, 64.1, 35.3, 35.3, 31.7, 31.3, 21.5; IR ν 
2961 (m), 2872 (w), 2240 (w), 1777 (s), 1746 (s), 1589 (w), 1466 (w), 1428 (w), 1242 (s), 1184 
(s), 1097 (s), 1046 (w), 1014 (m), 914 (w), 865 (w); HRMS (ESI) calcd. for C32H33INaO4+ [M+Na]+ 
631.1316; found 631.1321; Chiral HPLC conditions: ee = 87%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 0.5 mL/min, 40 min. tr (major) = 23.7 min and tr (minor) = 30.7 min. λ = 250 cm-1; 
[α]D 25.0 = ‐43.5 (c = 0.5, CHCl3). 
 
(R)-1-(2,6-Di-tert-butyl-4-methylphenoxy)-4-mesityl-1-oxobut-3-yn-2-yl 2-iodobenzoate (3a’) 
 
Following general procedure B, 1-[2,4,6-trimethylphenylethynyl]-1,2-benziodoxol-3(1H)-one 
(2k) (58.5 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) 
(87 mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated 
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in vacuo and purified by flash chromatography using Et2O:pentane 1:35 as mobile phase to afford 
3a’ (97.0 mg, 0.149 mmol, 99%) as a white foam. Mp: 46.5–49.0 °C;TLC (Et2O:pentane, 1:35 
v/v): Rf = 0.1, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.01 (dd, J = 12.6, 7.8 Hz, 2H, ArH), 7.43 
(t, J = 7.6 Hz, 1H, ArH), 7.19 (t, J = 7.7 Hz, 1H, ArH), 7.14 (s, 1H, ArH), 7.13 (s, 1H, ArH), 6.87 
(s, 2H, ArH), 6.85 (s, 1H, OCHCC), 2.42 (s, 6H, 2 X ArCH3), 2.32 (s, 3H, ArCH3), 2.28 (s, 3H, 
ArCH3), 1.38 (s, 9H, C(CH3)3), 1.34 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 165.8, 164.6, 
145.7, 142.1, 141.8, 141.5, 141.0, 138.8, 135.2, 133.7, 133.2, 131.6, 128.0, 127.6, 127.2, 127.1, 
118.2, 94.6, 87.2, 87.1, 64.5, 35.3, 35.3, 31.6, 31.5, 21.5, 21.4, 21.0; IR ν 2966 (s), 2919 (m), 2230 
(w), 2105 (w), 1773 (m), 1746 (s), 1605 (w), 1592 (w), 1473 (m), 1428 (m), 1372 (w), 1241 (s), 
1190 (s), 1097 (s), 1047 (m), 1024 (m), 913 (w); HRMS (ESI) calcd. for C35H39INaO4+ [M+Na]+ 
673.1785; found 673.1799; Chiral HPLC conditions: ee = 91%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 0.5 mL/min, 40 min. tr (major) = 19.6 min and tr (minor) = 22.7 min. λ = 254 cm-





Following general procedure B, 1-[2-bromophenylethynyl]-1,2-benziodoxol-3(1H)-one (2l) (64.5 
mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 mg, 
0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in vacuo 
and purified by flash chromatography using toluene:pentane 1:1 as mobile phase to afford 3b’ (100 
mg, 0.145 mmol, 97%) as a white foam. Mp: 47.3–50.6 °C;TLC (toluene:pentane, 1:1 v/v): Rf = 
0.35, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 8.0 Hz, 2H, ArH), 7.61 (d, J = 7.9 Hz, 
1H, ArH), 7.55 (dd, J = 7.7, 1.7 Hz, 1H, ArH), 7.43 (t, J = 7.6 Hz, 1H, ArH), 7.30 (t, J = 7.5 Hz, 
1H, ArH), 7.26–7.16 (m, 2H, ArH), 7.13 (d, J = 6.9 Hz, 2H, ArH), 6.81 (s, 1H, OCHCC), 2.32 (s, 
3H, ArCH3), 1.40 (s, 9H, C(CH3)3), 1.37 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3): δ 165.2, 
164.5, 145.7, 142.1, 141.9, 141.5, 135.2, 133.8, 133.5, 133.3, 132.6, 131.8, 130.4, 128.0, 127.3, 
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127.1, 127.0, 125.9, 123.7, 94.6, 87.2, 84.4, 64.0, 35.3, 31.7, 31.4, 21.5; IR ν 2961 (m), 2922 (m), 
2242 (w), 2113 (w), 1776 (m), 1745 (m), 1588 (w), 1467 (m), 1427 (m), 1370 (w), 1238 (s), 1183 
(s), 1091 (s), 1042 (m), 1021 (m), 864 (w); HRMS (ESI) calcd. for C32H32BrINaO4+ [M+Na]+ 
709.0421; found 709.0432; Chiral HPLC conditions: ee = 88%; Chiralpak IA 99.75:0.25 
Hexane/iPrOH, 1 mL/min, 30 min. tr (major) = 15.7 min and tr (minor) = 20.2 min. λ = 254 cm-1. 





Following general procedure B, 1-[4-bromophenylethynyl]-1,2-benziodoxol-3(1H)-one (2m) 
(64.5 mg, 0.150 mmol, 1.00 equiv) and 2,6-di-tert-butyl-4-methylphenyl 2-diazoacetate (1k) (87 
mg, 0.30 mmol, 2.0 equiv) were stirred for 18 h. The crude reaction mixture was concentrated in 
vacuo and purified by flash chromatography using toluene:pentane 1:1 as mobile phase to afford 
3c’ (100 mg, 0.145 mmol, 97%) as a white foam. Mp: 59.0–61.5 °C;TLC (toluene:pentane, 1:1 
v/v): Rf = 0.35, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 7.9 Hz, 2H, ArH), 7.50 (d, J 
= 8.3 Hz, 2H, ArH), 7.44–7.38 (m, 3H, ArH), 7.19 (t, J = 7.7 Hz, 1H, ArH), 7.14 (d, J = 9.1 Hz, 
2H, ArH), 6.73 (s, 1H, OCHCC), 2.33 (s, 3H, ArCH3), 1.39 (s, 9H, C(CH3)3), 1.37 (s, 9H, C(CH3)3); 
13C NMR (100 MHz, CDCl3): δ 165.2, 164.5, 145.7, 142.0, 141.9, 141.5, 135.3, 133.4, 133.3, 
131.8, 131.7, 128.0, 127.4, 127.0, 123.8, 120.3, 94.6, 87.8, 81.3, 64.0, 35.3, 35.3, 31.7, 31.3, 21.5; 
IR ν 2964 (m), 2917 (w), 2243 (w), 2105 (w), 1775 (s), 1746 (s), 1590 (w), 1480 (m), 1427 (w), 
1242 (s), 1189 (s), 1096 (s), 1046 (m), 1018 (m), 914 (w), 865 (w); HRMS (ESI) calcd. for 
C32H32BrINaO4+ [M+Na]+ 709.0421; found 709.0427; Chiral HPLC conditions: ee = 87%; 
Chiralpak IA 99.75:0.25 Hexane/iPrOH, 1 mL/min, 30 min. tr (major) = 12.1 min and tr (minor) = 






2-yl 2-iodobenzoate (5) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-diazoacetate 
(1o) (68.0 mg, 0.300 mmol, 2.00 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 5 (85.0 mg, 0.136 mmol, 91%) as a white foam. Mp: 67.2–69.0 °C; TLC 
(Et2O:pentane, 1:40 v/v): Rf = 0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.00 (t, J = 7.6 Hz, 2H, 
ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.7 Hz, 1H, ArH), 5.93 (s, 1H, OCHCC), 4.88– 
4.73 (m, 1H, OCH), 2.15–1.92 (m, 2H), 1.69 (d, J = 11.7 Hz, 2H), 1.62–1.40 (m, 2H), 1.16–1.04 
(m, 24H), 0.91 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H), 0.80–0.74 (m, 3H); 13C NMR (100 
MHz, CDCl3): δ 165.0, 164.9, 141.5, 133.5, 133.2, 131.9, 128.0, 97.5, 94.5, 90.3, 76.9, 64.2, 46.9, 
40.5, 34.1, 31.4, 25.7, 23.0, 21.9, 20.8, 18.5, 15.8, 11.0; IR ν 2956 (s), 2872 (s), 1748 (s), 1584 (w), 
1463 (m), 1383 (w), 1323 (w), 1241 (s), 1213 (m), 1075 (s), 1026 (m), 886 (w); HRMS (ESI) calcd. 
for C30H45INaO4Si+ [M+Na]+ 647.2024; found 647.2016; Chiral HPLC conditions: dr = 95:5; 
Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.3 mL/min, 31 min. tr (major) = 23.1 min. and tr (minor) 
= 25.2 min. λ = 214 cm-1; [α]D 25.0 = -34.2 (c = 0.5, CHCl3). 
 
(S)-1-(((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-




Following general procedure C, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 2-diazoacetate 
(1o) (68.0 mg, 0.300 mmol, 2.00 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 6 (90.0 mg, 0.144 mmol, 96%) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 
v/v): Rf = 0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 7.9 Hz, 1H, ArH), 7.97 (d, J = 
7.8 Hz, 1H, ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.6 Hz, 1H, ArH), 5.93 (s, 1H, 
OCHCC), 4.82 (td, J = 10.9, 4.2 Hz, 1H, OCH), 2.09–1.95 (m, 2H), 1.69 (d, J = 11.7 Hz, 2H), 
1.56–1.39 (m, 2H), 1.15–0.98 (m, 24H), 0.96–0.84 (m, 6H), 0.80–0.74 (m, 3H); 13C NMR (100 
MHz, CDCl3): δ 165.0, 165.0, 141.4, 133.5, 133.2, 131.8, 127.9, 97.6, 94.5, 90.3, 76.7, 64.2, 46.8, 
40.4, 34.1, 31.3, 26.1, 23.3, 21.9, 20.7, 18.5, 16.3, 11.0; IR ν 2949 (s), 2866 (s), 2189 (w), 2117 
(w), 1745 (s), 1578 (w), 1462 (m), 1377 (w), 1322 (m), 1241 (s), 1206 (s), 1092 (s), 1016 (s), 915 
(w), 885 (m); HRMS (ESI) calcd. for C30H45INaO4Si+ [M+Na]+ 647.2024; found 647.2016; Chiral 
HPLC conditions: dr = 6:94; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.3 mL/min, 50 min. tr 
(minor) = 21.6 min. and tr (major) = 22.6 min. λ = 214 cm-1; [α]D 25.0 = -6.0 (c = 0.5, CHCl3). 
 
(R)-1-(((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-




Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-diazoacetate 
(1p) (68.0 mg, 0.300 mmol, 2.00 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 7 (85.0 mg, 0.136 mmol, 91%) as a colorless thick liquid. TLC (Et2O:pentane, 1:40 
v/v): Rf = 0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 7.9 Hz, 1H, ArH), 7.97 (d, J = 
7.8 Hz, 1H, ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.6 Hz, 1H, ArH), 5.93 (s, 1H, 
OCHCC), 4.82 (td, J = 10.9, 4.2 Hz, 1H, OCH), 2.09–1.95 (m, 2H), 1.69 (d, J = 11.7 Hz, 2H), 
1.55–1.37 (m, 2H), 1.15–0.98 (m, 24H), 0.95–0.83 (m, 6H), 0.80–0.74 (m, 3H); 13C NMR (100 
MHz, CDCl3): δ 165.0, 165.0, 141.4, 133.5, 133.2, 131.8, 128.0, 97.6, 94.5, 90.3, 76.7, 64.2, 46.9, 
40.4, 34.1, 31.3, 26.1, 23.3, 21.9, 20.7, 18.5, 16.3, 11.0; IR ν 2952 (s), 2868 (s), 2188 (w), 2106 
(w), 1746 (s), 1589 (w), 1460 (m), 1376 (w), 1322 (m), 1242 (s), 1210 (s), 1090 (s), 1021 (m), 958 
(w), 897 (w), 886 (w); HRMS (ESI) calcd. for C30H45INaO4Si+ [M+Na]+ 647.2024; found 
647.2016; Chiral HPLC conditions: dr = 93.5:6.5; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.3 
mL/min, 50 min. tr (major) = 19.1 min. and tr (minor) = 32.0 min. λ = 250 cm-1; [α]D 25.0 = +4.7 (c 
= 0.5, CHCl3). 
 
(S)-1-(((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-
2-yl 2-iodobenzoate (8) 
 
Following general procedure C, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and (1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 2-diazoacetate 
(1p) (68.0 mg, 0.300 mmol, 2.00 equiv) were stirred for 18 h. The crude reaction mixture was 
concentrated in vacuo and purified by flash chromatography using Et2O:pentane 1:70 as mobile 
phase to afford 8 (85.0 mg, 0.136 mmol, 91%) as a white foam. Mp: 67.2–69.0 °C; TLC 
(Et2O:pentane, 1:40 v/v): Rf = 0.2, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.00 (t, J = 7.5 Hz, 2H, 
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ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.18 (t, J = 7.6 Hz, 1H, ArH), 5.93 (s, 1H, OCHCC), 4.81 (td, 
J = 10.9, 4.3 Hz, 1H, OCH), 2.14–1.91 (m, 2H), 1.69 (d, J = 11.7 Hz, 2H), 1.47 (t, J = 10.2 Hz, 
2H), 1.13–0.99 (m, 24H), 0.91 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H), 0.80–0.74 (m, 3H); 
13C NMR (100 MHz, CDCl3): δ 165.0, 164.9, 141.5, 133.4, 133.2, 131.9, 128.0, 97.4, 94.5, 90.3, 
76.9, 64.1, 46.8, 40.5, 34.0, 31.4, 25.7, 22.9, 21.9, 20.8, 18.5, 15.8, 11.0; IR ν 2952 (s), 2868 (s), 
2116 (w), 1746 (s), 1588 (w), 1462 (m), 1376 (w), 1322 (m), 1242 (s), 1210 (s), 1090 (s), 1021 
(m), 914 (w), 886 (w); HRMS (ESI) calcd. for C30H45INaO4Si+ [M+Na]+ 647.2024; found 
647.2016; Chiral HPLC conditions: dr = 5:95; Chiralpak IB 99.75:0.25 Hexane/iPrOH, 0.3 
mL/min, 50 min. tr (minor) = 19.3 min. and tr (major) = 30.9 min. λ = 254 cm-1; [α]D 25.0 = +39.1 




2-yl 2-iodobenzoate (9) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-
2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl 2-
diazoacetate (1q) (107 mg, 0.300 mmol, 2.00 equiv) were stirred for 18 h. The crude reaction 
mixture was concentrated in vacuo and purified by flash chromatography using EtOAc:pentane 
1:10 as mobile phase to afford 9 (100 mg, 0.132 mmol, 88%) as colorless thick liquid. TLC 
(EtOAc:pentane, 1:10 v/v): Rf = 0.24, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.00 (t, J = 8.9 Hz, 
2H, ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.19 (t, J = 7.7 Hz, 1H, ArH), 5.95 (s, 1H, OCHCC), 5.42 
(d, J = 5.1 Hz, 1H, olefinic H), 4.78–4.70 (m, 1H, OCH), 2.57–2.33 (m, 3H), 2.13–2.04 (m, 2H), 
2.00–1.79 (m, 4H), 1.76–1.59 (m, 4H), 1.58–1.40 (m, 2H), 1.38–1.21 (m, 2H), 1.22–1.13 (m, 2H), 
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1.09 (s, 21H), 1.04 (s, 3H), 0.88 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 221.0, 164.9, 164.8, 141.5, 
139.4, 133.4, 133.2, 131.8, 128.0, 122.3, 97.6, 94.5, 90.5, 76.2, 64.0, 51.6, 50.0, 47.5, 37.7, 36.8, 
36.7, 35.8, 31.4, 31.4, 30.7, 27.2, 21.8, 20.3, 19.2, 18.5, 13.5, 11.0; IR ν 3056 (w), 2948 (m), 2867 
(m), 2190 (w), 1739 (s), 1464 (w), 1265 (s), 1212 (m), 1095 (m), 1018 (m), 885 (w); HRMS (ESI) 
calcd. for C39H53INaO5Si+ [M+Na]+ 779.2599; found 779.2598; Chiral HPLC conditions: dr = 
91:9; Chiralpak IB 95:5 Hexane/iPrOH, 1 mL/min, 31 min. tr (minor) = 15.9 min. and tr (major) = 




1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl 2-iodobenzoate (10) 
 
Following general procedure A, 1-[(triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (2a) 
(65.0 mg, 0.150 mmol, 1.00 equiv) and 3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-
methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H 
cyclopenta[a]phenanthren-3-yl 2-diazoacetate (1r) (136 mg, 0.300 mmol, 2.00 equiv) were stirred 
for 18 h. The crude reaction mixture was concentrated in vacuo and purified by flash 
chromatography using Et2O:pentane 1:70 as mobile phase to afford 10 (118 mg, 0.138 mmol, 92%) 
as a white foam. Mp: 43.0–46.5 °C; TLC (Et2O:pentane, 1:50 v/v): Rf = 0.2, KMnO4; 1H NMR 
(400 MHz, CDCl3): δ 8.00 (t, J = 8.8 Hz, 2H, ArH), 7.44 (t, J = 7.6 Hz, 1H, ArH), 7.19 (t, J = 7.6 
Hz, 1H, ArH), 5.96 (s, 1H, OCHCC), 5.39 (d, J = 4.7 Hz, 1H, olefinic H), 4.74 (tt, J = 11.8, 4.6 
Hz, 1H, OCH), 2.45–2.33 (m, 2H), 2.09–1.75 (m, 5H), 1.74–0.94 (m, 45H), 0.91 (d, J = 6.5 Hz, 
3H), 0.86 (d, J = 6.5 Hz, 6H), 0.67 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 164.9, 164.8, 141.5, 
139.2, 133.4, 133.2, 131.8, 128.0, 123.1, 97.7, 94.5, 90.4, 76.5, 64.1, 56.6, 56.1, 49.9, 42.3, 39.7, 
39.5, 37.8, 36.8, 36.5, 36.2, 35.8, 31.9, 31.8, 28.2, 28.0, 27.3, 24.3, 23.8, 22.8, 22.6, 21.0, 19.2, 
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18.7, 18.5, 11.8, 11.1; IR ν 2945 (s), 2866 (s), 2256 (w), 2188 (w), 1747 (s), 1579 (w), 1463 (m), 
1376 (m), 1323 (m), 1240 (s), 1208 (s), 1088 (s), 1017 (s), 914 (m); HRMS (ESI) calcd. for 
C47H71INaO4Si+ [M+Na]+ 877.4059; found 877.4069; Chiral HPLC conditions: dr = 89:11; 
Chiralpak IB 99:1 Hexane/iPrOH, 0.25 mL/min, 40 min. tr (minor) = 30.8 min. and tr (major) = 





7. Product modifications 
(R)-2,6-Di-tert-butyl-4-methylphenyl 2-hydroxy-4-(triisopropylsilyl)but-3-ynoate (11) 
 
(R)-1-(2,6-Di-tert-butyl-4-methylphenoxy)-1-oxo-4-(triisopropylsilyl)but-3-yn-2-yl-2-iodo 
benzoate (3k) (83 mg, 0.12 mmol, 1.0 equiv) was dissolved in anhydrous toluene (1 mL) under N2 
in a 5 mL microwave vial. Then DIBAL-H (1.2 M in toluene, 0.220 mL, 0.264 mmol, 2.20 equiv) 
was added under N2 at -78 °C and stirred for 1h. The resulting clear solution was quenched by the 
addition of sat. aq. potassium sodium tartrate (2 mL) and the mixture was stirred for 1 h at room 
temperature. Then the reaction mixture was diluted with water (5 mL) and extracted with EtOAc 
(3 X 10 mL). The combined organic layers were dried over MgSO4 and the solvent removed in 
vacuo. The crude product was purified by column chromatography using 1:20 EtOAc:pentane to 
afford (R)-2,6-di-tert-butyl-4-methylphenyl 2-hydroxy-4-(triisopropylsilyl)but-3-ynoate (11) (54.5 
mg, 0.119 mmol, 99%) as a thick liquid. TLC (EtOAc:pentane, 1:15 v/v): Rf = 0.44, KMnO4; 1H 
NMR (400 MHz, CDCl3): δ 7.14 (s, 2H, ArH), 5.21 (s, 1H, OCHCC), 3.06 (s, 1H, OH), 2.33 (s, 
3H, ArCH3), 1.37 (s, 9H, C(CH3)3), 1.33 (s, 9H, C(CH3)3), 1.11 (s, 21H, TIPS); 13C NMR (100 
MHz, CDCl3): δ 170.2, 145.9, 142.2, 141.6, 135.3, 127.2, 127.1, 100.5, 90.5, 63.6, 35.4, 35.2, 31.6, 
31.5, 21.5, 18.5, 11.1; IR ν 3470 (w), 2953 (s), 2870 (s), 2724 (w), 2178 (w), 1762 (s), 1599 (w), 
1465 (m), 1426 (m), 1373 (m), 1191 (s), 1100 (s), 1019 (m), 889 (m); HRMS (ESI) calcd. for 
C28H46NaO3Si+ [M+Na]+ 481.3108; found 481.3114; Chiral HPLC conditions: ee = 95%; Chiralpak 
IA 99:1 Hexane/iPrOH, 1 mL/min, 20 min. tr (major) = 10.1 min. and tr (minor) = 12.2 min. λ = 







benzoate (3k) (207 mg, 0.300 mmol, 1.00 equiv) was dissolved in anhydrous THF (3 mL) under 
N2 in a 5 mL microwave vial. Then LiAlH4 (2.4 M in THF, 0.375 mL, 0.900 mmol, 3.00 equiv) 
was added under N2 at 0 °C and stirred for 1 h. The resulting solution was quenched by the addition 
of sat. aq. potassium sodium tartrate (5 mL) and the biphasic mixture was stirred for 1 h at room 
temperature. Then the reaction mixture was diluted with water (5 mL) and extracted with EtOAc 
(3 X 20 mL). The combined organic layers were dried over MgSO4 and the solvent removed in 
vacuo. The crude product was purified by column chromatography using 1:3 EtOAc:pentane to 
afford (R)-4-(triisopropylsilyl)but-3-yne-1,2-diol (12) (55.0 mg, 0.227 mmol, 76%) as a white 
solid. Mp: 75.1–77.0 °C; TLC (EtOAc:pentane, 1:3 v/v): Rf = 0.24, KMnO4; 1H NMR (400 MHz, 
CDCl3): δ 4.48 (dd, J = 6.7, 3.8 Hz, 1H, OCHCC), 3.79–3.61 (m, 2H, CH2OH), 2.27 (s, 2H, 2 X 
OH), 1.06 (s, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 104.9, 87.7, 66.8, 63.8, 18.5, 11.0; IR ν 
3300 (m), 2941 (s), 2867 (s), 2174 (w), 1463 (m), 1223 (w), 1089 (s), 1038 (s), 1009 (s), 882 (m); 
HRMS (ESI) calcd. for C13H26NaO2Si+ [M+Na]+ 265.1594; found 265.1601; [α]D 25.0 = ‐17.9 (c = 
0.5, CHCl3). 
Determination of the ee of 12: 
(R)-2-Hydroxy-4-(triisopropylsilyl)but-3-yn-1-yl 4-nitrobenzoate (79) 
 
(R)-4-(Triisopropylsilyl)but-3-yne-1,2-diol (12) (11.0 mg, 0.045 mmol, 1.00 equiv) and imidazole 
(6.8 mg, 0.10 mmol, 2.2 equiv) were dissolved in anhydrous DCM (0.45 mL) under N2 in a 5 mL 
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microwave vial. Then p-nitrobenzoyl chloride (78) (9.3 mg, 0.05 mmol, 1.1 equiv), which was 
dissolved in DCM (0.25 mL), was added under N2 at 0 °C. The reaction mixture was warmed-up 
to room temperature and stirred for 14 h. A sat. solution of NaHCO3 (2.5 mL) was added, and the 
reaction mixture was extracted with DCM (3 x 5 mL). The combined organic layers were dried 
over MgSO4 and the solvent removed in vacuo. The crude product was purified by column 
chromatography using 1:7 EtOAc:pentane as mobile phase to afford (R)-2-hydroxy-4-
(triisopropylsilyl)but-3-yn-1-yl 4-nitrobenzoate (79) (3.5 mg, 8.9 μmmol, 20%) as a thick yellow 
liquid. TLC (EtOAc:pentane, 1:7 v/v): Rf = 0.32, KMnO4; 1H NMR (400 MHz, CDCl3): δ 8.32–
8.24 (m, 4H, ArH), 4.78 (t, J = 5.0 Hz, 1H, OCHCC), 4.59–4.46 (m, 2H, OCH2), 2.22 (bs, 1H, 
OH), 1.05 (s, 21H, TIPS); 13C NMR (100 MHz, CDCl3): δ 164.5, 150.7, 135.1, 130.9, 123.5, 103.8, 
88.4, 68.5, 61.4, 18.5, 11.0; IR ν 3414 (w), 3114 (w), 2947 (m), 2867 (m), 1736 (s), 1608 (w), 1531 
(s), 1465 (w), 1349 (m), 1276 (s), 1259 (s), 1097 (s), 1053 (m), 1017 (m); HRMS (ESI) calcd. for 
C20H29AgNO5Si+ [M+Ag]+ 498.0860; found 498.0864; Chiral HPLC conditions: ee = 92%; 
Chiralpak IA 95:5 Hexane/iPrOH, 1 mL/min, 31 min. tr (major) = 10.0 min. and tr (minor) = 14.8 










Empirical formula  C36 H51 I O4 Si 
Formula weight  702.76 
Temperature  140.00(10) K 
Wavelength  1.54184 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 9.3812(2) Å = 90°. 
b = 12.8730(2) Å = 90°. 
c = 29.8093(7) Å  = 90°. 
Volume 3599.90(13) Å3 
Z 4 
Density (calculated) 1.297 Mg/m3 
Absorption coefficient 7.573 mm-1 
F(000) 1464 
Crystal size 0.486 x 0.253 x 0.180 mm3 
Theta range for data collection 3.740 to 73.880°. 
Index ranges -8 ≤ h ≤ 11, -15 ≤ k ≤ 14, -36 ≤ l ≤ 37 
Reflections collected 25820 
Independent reflections 7160 [R(int) = 0.0451] 
Completeness to theta = 67.684° 100.0 % 
Absorption correction Sphere 
Max. and min. transmission 0.14825 and 0.05124 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7160 / 111 / 444 
Goodness-of-fit on F2 1.073 
Final R indices [I>2sigma(I)] R1 = 0.0491, wR2 = 0.1364 
R indices (all data) R1 = 0.0494, wR2 = 0.1368 
Absolute structure parameter 0.003(5) 
Largest diff. peak and hole 2.291 and -0.622 e.Å-3 
 
 
Stereochemical model for the reaction 
A highly speculative model for rationalizing the observed absolute configuration is proposed in 
Figure S1 based on the following assumption: 
1) A tricoordinate copper carbene complex with a 90° angle between the carbene and the ligand 
plane, based on the proposed structure of this type of complexes. 31 
2) First and enantiodeterminating step if the attack of the carboxylate group of the reagent onto the 
copper. 
3) The attack of the carboxylate occurs in the free quadrant on the opposite side of the ester group. 
4) The following alkyne transfer occurs under retention of configuration. 
This model allows rationalizing the observed absolute configuration. However, as the mechanism 
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10. Spectra of new compounds 
1H-NMR (400 MHz, CDCl3) of compound 3a 
 






















1H-NMR (400 MHz, CDCl3) of compound 3b 
 
 





















1H-NMR (400 MHz, CDCl3) of compound 3c 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3d 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3e 
 
 
























1H-NMR (400 MHz, CDCl3) of compound 3f 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3g 
 
 





















1H-NMR (400 MHz, CDCl3) of compound 3h 
 
 
























1H-NMR (400 MHz, CDCl3) of compound 3i 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3j 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3k 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3l 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3m 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3n 
 
 
























1H-NMR (400 MHz, CDCl3) of compound 3o 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3p 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3q 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3r 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3s 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 3t 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3u 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3v 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3w 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3x 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3y 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3z 
 
 

















IR of compound 3z 
S166 
 
1H-NMR (400 MHz, CDCl3) of compound 3a’ 
 
 























1H-NMR (400 MHz, CDCl3) of compound 3b’ 
 
 
























1H-NMR (400 MHz, CDCl3) of compound 3c’ 
 
 























1H-NMR (400 MHz, CDCl3) of compound 5 
 
 
























1H-NMR (400 MHz, CDCl3) of compound 6 
 
 























1H-NMR (400 MHz, CDCl3) of compound 7 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 8 
 
 























1H-NMR (400 MHz, CDCl3) of compound 9 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 10 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 11 
 
 






















1H-NMR (400 MHz, CDCl3) of compound 12 
 
 









1H-NMR (400 MHz, CDCl3) of compound 79 
 
 
















IR of compound 79 
 
 
